{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":189,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":189,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"dedd6f837dfb","filters":{"venue":"Hematological Oncology"}},"results":[{"id":"W2130207527","doi":"10.1002/hon.802","title":"Fertility among female hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy","year":2006,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Connaught Fund","keywords":"ABVD; Medicine; Pregnancy; Dacarbazine; Fertility; Vinblastine; Pregnancy rate; Chemotherapy regimen; Chemotherapy; Obstetrics; Gynecology; Pediatrics; Surgery; Cyclophosphamide; Population; Vincristine","authors":[{"name":"David Hodgson","is_ca":true},{"name":"Melania Pintilie","is_ca":true},{"name":"Leah Gitterman","is_ca":true},{"name":"Beth DeWitt","is_ca":true},{"name":"C Buckley","is_ca":true},{"name":"Sameera Ahmed","is_ca":true},{"name":"Katherine Smith","is_ca":true},{"name":"A. K. Schwartz","is_ca":true},{"name":"Richard Tsang","is_ca":true},{"name":"Michael Crump","is_ca":true},{"name":"Woodrow Wells","is_ca":true},{"name":"A. Sun","is_ca":true},{"name":"Mary Gospodarowicz","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03023768325960741,"gpt":0.3238924048666322,"spread":0.2936547216070248,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005467445,0.00009330639,0.0002095012,0.0006087396,0.0002425858,0.0003387794,0.0001348658,0.0002240854,0.0009040737],"category_scores_gemma":[0.003443115,0.0001358655,0.0002269425,0.0004006947,0.0002443677,0.0002218246,0.0002716607,0.0002317368,0.0001013076],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001904444,"about_ca_system_score_gemma":0.0001352135,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001452589,"about_ca_topic_score_gemma":0.00132437,"domain_scores_codex":[0.9996731,0.0001450161,0.00002770437,0.00003400113,0.00006375833,0.00005652091],"domain_scores_gemma":[0.998643,0.0004731887,0.0006414024,0.00005180278,0.00006174355,0.0001288198],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00006334099,0.00001764211,0.9964674,0.000006076408,0.00001113681,0.000142772,0.0001749783,0.00002074241,0.0001039608,0.00001463932,0.00004831991,0.002928996],"study_design_scores_gemma":[0.000005126612,0.0002671327,0.9974694,0.00000996611,0.00002068939,0.001328962,0.0003836433,0.0001268466,0.0000956424,0.00002211424,0.0002673389,0.000003285597],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9994258,0.0002829526,0.00002739541,0.00002260886,0.000001645257,0.00000420471,0.00004995186,0.000001625404,0.000183817],"genre_scores_gemma":[0.9996736,0.0001669763,0.00002045944,0.00001447534,0.000004094082,0.000003723611,0.00004159528,3.572977e-7,0.0000747719],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001452589,"threshold_uncertainty_score":0.003024459,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2951720456","doi":"10.1002/hon.5_2629","title":"ROBUST: First report of phase III randomized study of lenalidomide/R‐CHOP (R<sup>2</sup>‐CHOP) vs placebo/R‐CHOP in previously untreated ABC‐type diffuse large B‐cell lymphoma","year":2019,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Lenalidomide; Medicine; Diffuse large B-cell lymphoma; CHOP; Internal medicine; Rituximab; Clinical endpoint; Placebo; Gastroenterology; Lymphoma; Vincristine; Oncology; Pathology; Randomized controlled trial; Chemotherapy; Cyclophosphamide; Multiple myeloma","authors":[{"name":"Umberto Vitolo","is_ca":false},{"name":"Thomas E. Witzig","is_ca":false},{"name":"Randy D. Gascoyne","is_ca":true},{"name":"David W. Scott","is_ca":true},{"name":"Q. Zhang","is_ca":false},{"name":"Wojciech Jurczak","is_ca":false},{"name":"Muhıt Özcan","is_ca":false},{"name":"Xin Hong","is_ca":false},{"name":"Jun Zhu","is_ca":false},{"name":"Jie Jin","is_ca":false},{"name":"David Belada","is_ca":false},{"name":"Juan Bergua","is_ca":false},{"name":"Francesco Piazza","is_ca":false},{"name":"Heidi Móciková","is_ca":false},{"name":"Anna Lia Molinari","is_ca":false},{"name":"Dok Hyun Yoon","is_ca":false},{"name":"Federica Cavallo","is_ca":false},{"name":"Monica Tani","is_ca":false},{"name":"Koji Izutsu","is_ca":false},{"name":"Koji Kato","is_ca":false},{"name":"M. S. Czuczman","is_ca":false},{"name":"S. J. Hersey","is_ca":false},{"name":"Adrian Kilcoyne","is_ca":false},{"name":"Jacqueline Russo","is_ca":false},{"name":"Krista Hudak","is_ca":false},{"name":"J. Zhang","is_ca":false},{"name":"Annalisa Chiappella","is_ca":false},{"name":"Grzegorz S. Nowakowski","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02707653928937821,"gpt":0.3086064026914633,"spread":0.2815298634020851,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00461751,0.002375016,0.003550977,0.0004247848,0.0005651594,0.001953002,0.001390555,0.002210484,0.01048786],"category_scores_gemma":[0.003602759,0.0009422397,0.002695225,0.0004141925,0.001177091,0.001342881,0.0007291252,0.003004834,0.002315526],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009850824,"about_ca_system_score_gemma":0.001200804,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005806449,"about_ca_topic_score_gemma":0.001806624,"domain_scores_codex":[0.998321,0.001059954,0.0001037527,0.0002581584,0.0001209859,0.0001361122],"domain_scores_gemma":[0.9982981,0.0005284326,0.0004327522,0.0002321083,0.0001334207,0.000375256],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.961536,0.007232192,0.0008193025,0.000895889,0.00323167,0.00005690124,0.00004719398,0.0004479942,0.003263571,0.0001896661,0.003284459,0.01899504],"study_design_scores_gemma":[0.9273438,0.06646573,0.001702343,0.00006251355,0.001468033,0.00005070131,0.00001846595,0.0003894781,0.0004538274,0.0003426457,0.001677375,0.00002514221],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9234453,0.02222018,0.004425181,0.003830401,0.001948754,0.01847177,0.01479074,0.0008408558,0.01002675],"genre_scores_gemma":[0.9560991,0.006399056,0.005911607,0.004325557,0.00123571,0.01235159,0.007272674,0.000156123,0.006248575],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01048786,"threshold_uncertainty_score":0.03508538,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2968968970","doi":"10.1002/hon.2666","title":"Rituximab in primary central nervous system lymphoma—A systematic review and meta‐analysis","year":2019,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Impact","funders":"Cancer Research UK; European Hematology Association","keywords":"Rituximab; Medicine; Primary central nervous system lymphoma; Internal medicine; Oncology; Lymphoma; Randomized controlled trial; Clinical trial; Meta-analysis; Diffuse large B-cell lymphoma","authors":[{"name":"Andreas M. Schmitt","is_ca":false},{"name":"Amanda K. Herbrand","is_ca":false},{"name":"Christopher P. Fox","is_ca":false},{"name":"Katerina Bakunina","is_ca":false},{"name":"Jacoline E. C. Bromberg","is_ca":false},{"name":"Kate Cwynarski","is_ca":false},{"name":"Jeanette K. Doorduijn","is_ca":false},{"name":"Andrés J.M. Ferreri","is_ca":false},{"name":"Gerald Illerhaus","is_ca":false},{"name":"Samar Issa","is_ca":false},{"name":"Elisabeth Schorb","is_ca":false},{"name":"Emanuele Zucca","is_ca":false},{"name":"Lars G. Hemkens","is_ca":false},{"name":"Stefan Schandelmaier","is_ca":true},{"name":"Benjamin Kasenda","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09136588791526158,"gpt":0.368136584382143,"spread":0.2767706964668814,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01164052,0.002511113,0.01802899,0.004490823,0.0005414899,0.003034977,0.001996774,0.002200785,0.004100837],"category_scores_gemma":[0.02592428,0.00138588,0.02973641,0.005852826,0.0006050743,0.001661948,0.001343112,0.001944897,0.0004145968],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002890219,"about_ca_system_score_gemma":0.003274652,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007905003,"about_ca_topic_score_gemma":0.01541657,"domain_scores_codex":[0.9912187,0.004595415,0.00225709,0.0007702388,0.0008778374,0.0002806044],"domain_scores_gemma":[0.9865868,0.009634654,0.002156571,0.0003746795,0.001037786,0.0002095229],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001823288,0.00002652598,0.001570529,0.4470279,0.5393474,0.0001084722,0.00006274871,0.0004414759,0.0001607159,0.000137606,0.0006249933,0.008668502],"study_design_scores_gemma":[0.0008401636,0.0002023356,0.00228263,0.03580947,0.958401,0.00008802827,0.00003707234,0.0001950164,0.0000866403,0.0002065523,0.001828287,0.0000227719],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003496431,0.9948278,0.000372051,0.0001781724,0.0001285287,0.0002968953,0.000426368,0.00001980689,0.0002539824],"genre_scores_gemma":[0.1470866,0.847119,0.001759058,0.001139877,0.0002501564,0.001360168,0.0008244929,0.00003306488,0.0004276267],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01802899,"threshold_uncertainty_score":0.0615617,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2002534044","doi":"10.1002/hon.743","title":"Radiation therapy for localized low-grade non-Hodgkin's lymphomas","year":2005,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Lymphoma; Medicine; MALT lymphoma; Radiation therapy; Follicular lymphoma; Helicobacter pylori; Marginal zone; Gastric lymphoma; Mucosa-associated lymphoid tissue; Stage (stratigraphy); Non-Hodgkin's lymphoma; Gastroenterology; Disease; Internal medicine; Pathology; Oncology; B cell; Immunology; Biology; Antibody","authors":[{"name":"Richard Tsang","is_ca":true},{"name":"Mary Gospodarowicz","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08553989961677713,"gpt":0.4215549297981744,"spread":0.3360150301813973,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000310487,0.0008961056,0.001746834,0.002535603,0.000294841,0.0006256897,0.0008125207,0.0008188584,0.004191302],"category_scores_gemma":[0.0006475713,0.0002386111,0.0005533403,0.002920344,0.0003993415,0.0009507975,0.0004659967,0.001190674,0.002988279],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005366954,"about_ca_system_score_gemma":0.0006085885,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001257412,"about_ca_topic_score_gemma":0.002133183,"domain_scores_codex":[0.9998317,0.00003327622,0.00002515652,0.00003383365,0.00006236275,0.00001372623],"domain_scores_gemma":[0.9997559,0.0001170356,0.00004458823,0.0000109849,0.00005223492,0.00001932353],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005094247,0.00006056479,0.0001926087,0.01310499,0.00007721542,0.0003953376,0.00006103513,0.0002741093,0.0009812997,0.0006021276,0.02242962,0.9617702],"study_design_scores_gemma":[0.00003617967,0.0001250688,0.002206657,0.006609391,0.0002061193,0.007574265,0.00008989328,0.00009232797,0.0007356756,0.001241566,0.9810601,0.00002278783],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001223335,0.9986306,0.00008801821,0.00007475411,0.00008493391,0.000004429914,0.000009020527,0.000007492142,0.0009783664],"genre_scores_gemma":[0.0007745578,0.9982486,0.0001372895,0.0001013004,0.00009879375,0.000005852747,0.00002562653,0.000001793622,0.0006062749],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004191302,"threshold_uncertainty_score":0.01402134,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2621746631","doi":"10.1002/hon.2437_3","title":"INTERIM REPORT FROM A PHASE 2 MULTICENTER STUDY OF TAZEMETOSTAT, AN EZH2 INHIBITOR, IN PATIENTS WITH RELAPSED OR REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMAS","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Oncology; Clinical endpoint; Interim analysis; Ixazomib; Phases of clinical research; Adverse effect; EZH2; Surrogate endpoint; Pharmacology; Refractory (planetary science); Clinical trial; Lenalidomide; Multiple myeloma","authors":[{"name":"Franck Morschhauser","is_ca":false},{"name":"Gilles Salles","is_ca":false},{"name":"Pam McKay","is_ca":false},{"name":"Hervé Tilly","is_ca":false},{"name":"Anne Dorothée Schmitt","is_ca":false},{"name":"John F. Gerecitano","is_ca":false},{"name":"Peter Johnson","is_ca":false},{"name":"Steven Le Gouill","is_ca":false},{"name":"Michael Dickinson","is_ca":false},{"name":"Christophe Fruchart","is_ca":false},{"name":"Thierry Lamy","is_ca":false},{"name":"Aristeidis Chaidos","is_ca":false},{"name":"Wojciech Jurczak","is_ca":false},{"name":"Stephen Opat","is_ca":false},{"name":"John Radford","is_ca":false},{"name":"Pier Luigi Zinzani","is_ca":false},{"name":"Sarit Assouline","is_ca":true},{"name":"Guillaume Cartron","is_ca":false},{"name":"Alicia Clawson","is_ca":false},{"name":"N. Picazio","is_ca":false},{"name":"Scott Ribich","is_ca":false},{"name":"Stephen J. Blakemore","is_ca":false},{"name":"John Larus","is_ca":false},{"name":"Harry Miao","is_ca":false},{"name":"Peter Ho","is_ca":false},{"name":"Vincent Ribrag","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03091780164131205,"gpt":0.3516476903810811,"spread":0.320729888739769,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004799916,0.001149355,0.001661461,0.0003364047,0.0004182968,0.001109225,0.000621543,0.00136815,0.007691439],"category_scores_gemma":[0.002141649,0.0004475421,0.001239293,0.0003543167,0.0003087043,0.00076659,0.0004633128,0.001742833,0.001754158],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005279495,"about_ca_system_score_gemma":0.001180522,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005401982,"about_ca_topic_score_gemma":0.001170351,"domain_scores_codex":[0.9990038,0.0004662818,0.00009499797,0.0001354602,0.0001503482,0.0001490878],"domain_scores_gemma":[0.9980268,0.0004370386,0.0004159967,0.0001635171,0.0002912329,0.0006653615],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7084281,0.01622187,0.03116257,0.001719289,0.006213245,0.0009150788,0.000284341,0.002691143,0.03764419,0.0003334532,0.04843538,0.1459514],"study_design_scores_gemma":[0.4649191,0.3647766,0.1118436,0.000197807,0.00401303,0.001006877,0.00008802173,0.001231305,0.01000249,0.000526128,0.04131801,0.00007700724],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8608244,0.0159935,0.006749229,0.004528557,0.001731077,0.01847878,0.06944618,0.0007569697,0.02149137],"genre_scores_gemma":[0.8836017,0.005143676,0.007064644,0.006045365,0.001376922,0.01533246,0.06408276,0.0002089143,0.01714351],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007691439,"threshold_uncertainty_score":0.02573043,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2167849560","doi":"10.1002/hon.703","title":"Increasing incidence of non‐Hodgkin's lymphoma in Canada, 1970–1996: age–period–cohort analysis","year":2003,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Institute of Population and Public Health; Health Canada; University of Ottawa","funders":"","keywords":"Incidence (geometry); Medicine; Cohort; Lymphoma; Non-Hodgkin's lymphoma; Cohort effect; Cancer registry; Demography; Hodgkin lymphoma; Cohort study; Cancer; Pediatrics; Internal medicine","authors":[{"name":"Shiliang Liu","is_ca":true},{"name":"R Semenciw","is_ca":true},{"name":"Yang Mao","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01736833943235416,"gpt":0.2922388759038446,"spread":0.2748705364714904,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007448423,0.0002692665,0.000399684,0.001765235,0.0009554196,0.0008477043,0.0007486916,0.0003276621,0.001770329],"category_scores_gemma":[0.001338014,0.000311252,0.0007997207,0.004113005,0.0003185637,0.0002640034,0.0005458366,0.0005675507,0.0001823287],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0109396,"about_ca_system_score_gemma":0.01346515,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.979119,"about_ca_topic_score_gemma":0.9782759,"domain_scores_codex":[0.9995197,0.00003895599,0.00003164923,0.00008693223,0.0001419503,0.000180799],"domain_scores_gemma":[0.9988015,0.00007335357,0.0002229295,0.00008444288,0.0005734632,0.0002443601],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001853248,0.00001301301,0.995218,0.00002444242,0.0001469708,0.00008501709,0.0001591003,0.0002314732,0.0001679127,0.00005662117,0.0004913399,0.003220835],"study_design_scores_gemma":[0.000009452826,0.00001965031,0.9981716,0.00001029981,0.00007706771,0.00007988455,0.0001784085,0.0003718926,0.00007217456,0.00001512773,0.0009880097,0.000006517274],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9872083,0.001264982,0.00025993,0.0001657637,0.00001381787,0.00005146794,0.009349869,0.00002443185,0.00166156],"genre_scores_gemma":[0.9933269,0.001016416,0.0002817666,0.00004926914,0.00000643506,0.00002236016,0.004090354,0.000007616343,0.001198977],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.020881,"threshold_uncertainty_score":0.0793727,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3032984305","doi":"10.1002/hon.2759","title":"Risk factors for high‐dose methotrexate associated acute kidney injury in patients with hematological malignancies","year":2020,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Methotrexate; Internal medicine; Creatinine; Acute kidney injury; Univariate analysis; Gastroenterology; Confidence interval; Adverse effect; Renal function; Hazard ratio; Surgery; Multivariate analysis","authors":[{"name":"Irina Amitai","is_ca":true},{"name":"Uri Rozovski","is_ca":false},{"name":"Reem El‐Saleh","is_ca":false},{"name":"Shai Shimony","is_ca":false},{"name":"Daniel Shepshelovich","is_ca":false},{"name":"Benaya Rozen‐Zvi","is_ca":false},{"name":"Pia Raanani","is_ca":false},{"name":"Anat Gafter‐Gvili","is_ca":false},{"name":"Ronit Gurion","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03139114837398717,"gpt":0.3225171573876341,"spread":0.2911260090136469,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000428078,0.0001941626,0.0002889104,0.0005552319,0.0003075592,0.0004806501,0.0002184138,0.0004010136,0.001884603],"category_scores_gemma":[0.002473077,0.0001727957,0.0003500815,0.001081828,0.0001987712,0.000424412,0.0003007244,0.0006233809,0.0001788353],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002144227,"about_ca_system_score_gemma":0.0003655076,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001669738,"about_ca_topic_score_gemma":0.0019203,"domain_scores_codex":[0.9996302,0.0001165462,0.00005153055,0.00005109809,0.00007867195,0.00007197332],"domain_scores_gemma":[0.9981158,0.000416627,0.001002328,0.00005405895,0.0001186774,0.000292562],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00004656132,0.00001127173,0.9993904,0.000004390813,0.0000127071,0.00006608823,0.000006405048,0.00001986894,0.0000493545,0.000005278944,0.00004487959,0.0003427481],"study_design_scores_gemma":[0.000006880655,0.00007111231,0.998769,0.000006488754,0.00002477297,0.0006055344,0.0000475565,0.0002657727,0.0000441762,0.00001864954,0.0001377748,0.000002326301],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984484,0.0007769637,0.00009419559,0.00009749146,0.0000103922,0.00000657199,0.0001848162,0.000004119987,0.000377055],"genre_scores_gemma":[0.99968,0.00008466464,0.00004050188,0.00001908112,0.00001315097,0.000003478079,0.00009609812,7.063478e-7,0.00006236775],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001884603,"threshold_uncertainty_score":0.006304622,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2046069452","doi":"10.1002/hon.931","title":"The clinical relevance of <i>Wilms Tumour 1</i> (<i>WT1</i>) gene mutations in acute leukaemia","year":2009,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Foothills Medical Centre","funders":"Medical Research Council; Research Councils UK; Cancer Research UK","keywords":"Wilms' tumor; Clinical significance; Oncology; Mutation; Karyotype; Medicine; Internal medicine; Gene; Gene mutation; Wilms tumour; Cancer research; Biology; Genetics; Chromosome","authors":[{"name":"Carolyn Owen","is_ca":true},{"name":"Jude Fitzgibbon","is_ca":false},{"name":"Peter Paschka","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04421241951846455,"gpt":0.392970906873712,"spread":0.3487584873552474,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004190069,0.0005905404,0.001090941,0.001793141,0.0002283727,0.0008098111,0.0006842552,0.0008351647,0.002416957],"category_scores_gemma":[0.0006853228,0.0002028316,0.0002631104,0.002016261,0.0003889874,0.001021464,0.000451712,0.001042159,0.002572322],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005518539,"about_ca_system_score_gemma":0.0008360246,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00114646,"about_ca_topic_score_gemma":0.001912835,"domain_scores_codex":[0.999862,0.00002403983,0.00002388872,0.00002558861,0.00005263853,0.00001181974],"domain_scores_gemma":[0.999712,0.0001037422,0.00004573668,0.000008334599,0.00009789154,0.00003221582],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000593557,0.00002551618,0.0004293456,0.006430438,0.0000502025,0.0008323691,0.00004935433,0.0002659078,0.001406092,0.001143598,0.02854969,0.9607581],"study_design_scores_gemma":[0.00001617854,0.00005429335,0.002173182,0.002055779,0.0001060284,0.007866054,0.00008294671,0.00007234685,0.0005265432,0.001182702,0.9858447,0.00001914514],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002503888,0.9977284,0.0001331262,0.000420649,0.0001891302,0.000003066301,0.00002002663,0.000008271382,0.001246997],"genre_scores_gemma":[0.0008884587,0.9979756,0.0001735053,0.0001646074,0.0001624529,0.000002979435,0.00002806837,0.000001561012,0.0006026736],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002416957,"threshold_uncertainty_score":0.008085549,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3109601420","doi":"10.1002/hon.2828","title":"Obinutuzumab‐related adverse events: A systematic review and meta‐analysis","year":2020,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Obinutuzumab; Medicine; Rituximab; Internal medicine; Chronic lymphocytic leukemia; Adverse effect; Relative risk; Oncology; Meta-analysis; Hazard ratio; Follicular lymphoma; Lymphoma; Leukemia; Confidence interval","authors":[{"name":"Irina Amitai","is_ca":true},{"name":"Anat Gafter‐Gvili","is_ca":false},{"name":"Liat Shargian","is_ca":false},{"name":"Pia Raanani","is_ca":false},{"name":"Ronit Gurion","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1180247417335613,"gpt":0.4309193846730987,"spread":0.3128946429395374,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009806219,0.002275283,0.01499634,0.005728683,0.0005241745,0.00266092,0.001778498,0.001619717,0.004012282],"category_scores_gemma":[0.02312715,0.001153147,0.03042826,0.007592471,0.0005078244,0.001295664,0.001209841,0.001659189,0.000318173],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002240497,"about_ca_system_score_gemma":0.002989534,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006475219,"about_ca_topic_score_gemma":0.0138954,"domain_scores_codex":[0.992633,0.003432258,0.00215951,0.0006952522,0.0008441214,0.0002357054],"domain_scores_gemma":[0.9852167,0.01092273,0.002154918,0.0003847495,0.001155835,0.0001651242],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001517449,0.0000255992,0.00290861,0.4547538,0.5255116,0.0001276077,0.00006609329,0.0007326586,0.0001650369,0.0001641479,0.0009243887,0.01310302],"study_design_scores_gemma":[0.0005372172,0.0001400216,0.003251769,0.0299879,0.963224,0.000108798,0.00003515176,0.0002406314,0.0001068303,0.0002206114,0.002123856,0.00002320298],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003333953,0.9947363,0.0004609524,0.0001496592,0.00008525363,0.0002328269,0.0007261847,0.00001950795,0.0002554042],"genre_scores_gemma":[0.1197149,0.8752796,0.001694018,0.0007640182,0.0001862026,0.001033604,0.000975963,0.00002797081,0.0003238236],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01499634,"threshold_uncertainty_score":0.05186087,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4383998685","doi":"10.1002/hon.3202","title":"Diffuse large B‐cell lymphoma","year":2023,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; Vincristine; Lymphoma; CHOP; Prednisone; Oncology; Clinical trial; Internal medicine; Intensive care medicine; Cyclophosphamide; Chemotherapy","authors":[{"name":"Allison Barraclough","is_ca":false},{"name":"Eliza A. Hawkes","is_ca":false},{"name":"Laurie H. Sehn","is_ca":true},{"name":"Sonali M. Smith","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1736930225114751,"gpt":0.4571691031232177,"spread":0.2834760806117427,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003925403,0.0006701937,0.001240232,0.0018433,0.0002395432,0.0008451552,0.000671314,0.0006514362,0.004694193],"category_scores_gemma":[0.0005925267,0.0001800462,0.0004095661,0.001700922,0.0002850395,0.00084077,0.000544406,0.001281604,0.002939103],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000614404,"about_ca_system_score_gemma":0.001000057,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001217359,"about_ca_topic_score_gemma":0.002587912,"domain_scores_codex":[0.9998569,0.00002205478,0.00001967303,0.00002946396,0.00005516627,0.00001664382],"domain_scores_gemma":[0.9998239,0.00007155878,0.00003029186,0.00000535802,0.00004822573,0.00002066668],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004903743,0.00002737642,0.0001236658,0.01347077,0.00007052835,0.0001175419,0.00002231859,0.0001174037,0.0006153817,0.001300405,0.05467763,0.9294079],"study_design_scores_gemma":[0.00002514017,0.00004997256,0.0007581347,0.005364583,0.0001188991,0.0018566,0.00002795353,0.00003617103,0.0002008093,0.0008573236,0.990692,0.00001241248],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005785324,0.9983523,0.00005042172,0.0002001966,0.0001624502,0.000004491348,0.00001914105,0.000006984455,0.0011462],"genre_scores_gemma":[0.0004634386,0.9985247,0.00006135946,0.0002442834,0.0001304774,0.000004804495,0.00004388292,0.000001015363,0.000526037],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004694193,"threshold_uncertainty_score":0.01570362,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2031242160","doi":"10.1002/hon.902","title":"Improved survival in red blood cell transfusion dependent patients with primary myelofibrosis (PMF) receiving iron chelation therapy","year":2009,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Myelofibrosis; Internal medicine; Gastroenterology; Splenectomy; White blood cell; Blood transfusion; Anemia; Surgery; Bone marrow","authors":[{"name":"Heather A. Leitch","is_ca":true},{"name":"Jocelyn M. Chase","is_ca":true},{"name":"Trisha A. Goodman","is_ca":true},{"name":"Hatoon Ezzat","is_ca":true},{"name":"M. D. Rollins","is_ca":true},{"name":"Dominic H.C. Wong","is_ca":true},{"name":"Maha A. Badawi","is_ca":true},{"name":"Chantal S. Leger","is_ca":true},{"name":"Khaled M. A. Ramadan","is_ca":true},{"name":"Michael J. Barnett","is_ca":true},{"name":"Lynda Foltz","is_ca":true},{"name":"Linda M. Vickars","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01549096739603593,"gpt":0.257920360962542,"spread":0.2424293935665061,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003399761,0.000147635,0.0003913002,0.000404912,0.0002567304,0.0003607621,0.0001206795,0.000297825,0.00088296],"category_scores_gemma":[0.001682272,0.00007756806,0.0002071212,0.000446908,0.0001963889,0.0002454832,0.0001970012,0.0002792423,0.0001663308],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002086856,"about_ca_system_score_gemma":0.0002012504,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006340792,"about_ca_topic_score_gemma":0.0009196685,"domain_scores_codex":[0.9998043,0.00005920102,0.00002203108,0.00003361205,0.00003343595,0.00004731495],"domain_scores_gemma":[0.9991341,0.0002128885,0.0003424103,0.00002589934,0.00005861725,0.0002260352],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007443176,0.00005633569,0.9881285,0.00002083369,0.00003577542,0.0009904851,0.0001228044,0.000127539,0.0008440907,0.00002187892,0.0002377261,0.008669682],"study_design_scores_gemma":[0.0000546344,0.001108666,0.9926441,0.00002484572,0.0000717255,0.004674747,0.0001181746,0.0003900901,0.0002385436,0.00005856247,0.0006095888,0.000006319393],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9988808,0.0006724214,0.00004725502,0.00004528274,0.000006669274,0.000003857094,0.00006205498,0.000003069603,0.0002786208],"genre_scores_gemma":[0.9995447,0.00018536,0.00004153027,0.00003171861,0.00001954509,0.000003122315,0.000118946,6.239445e-7,0.00005440626],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00088296,"threshold_uncertainty_score":0.002953768,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2951473081","doi":"10.1002/hon.127_2629","title":"HIGH RATE OF DURABLE COMPLETE REMISSION IN FOLLICULAR LYMPHOMA AFTER CD19 CAR‐T CELL IMMUNOTHERAPY","year":2019,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Follicular lymphoma; Chemoimmunotherapy; Fludarabine; Internal medicine; Lymphoma; Cyclophosphamide; Gastroenterology; Immunotherapy; Oncology; Rituximab; Immunology; Surgery; Chemotherapy; Cancer","authors":[{"name":"Alexandre V. Hirayama","is_ca":false},{"name":"Jordan Gauthier","is_ca":false},{"name":"Kevin A. Hay","is_ca":true},{"name":"Jenna Voutsinas","is_ca":false},{"name":"Qian Wu","is_ca":false},{"name":"Alyssa Sheih","is_ca":false},{"name":"Janaki Purushe","is_ca":false},{"name":"Barbara S. Pender","is_ca":false},{"name":"Reed M. Hawkins","is_ca":false},{"name":"Aesha Vakil","is_ca":false},{"name":"Ngan Thi Thuy Phi","is_ca":false},{"name":"Rachel N. Steinmetz","is_ca":false},{"name":"Stanley R. Riddell","is_ca":false},{"name":"David G. Maloney","is_ca":false},{"name":"Cameron J. Turtle","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02523600938608766,"gpt":0.3108993511486213,"spread":0.2856633417625337,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009279515,0.00009687123,0.0003613499,0.0001751153,0.0001813387,0.0002396501,0.0001797459,0.0003922569,0.002082449],"category_scores_gemma":[0.001702645,0.0000786416,0.0001816469,0.0001866373,0.0001634042,0.000227559,0.0002043882,0.0003124126,0.0003429232],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002646231,"about_ca_system_score_gemma":0.0002147171,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004868068,"about_ca_topic_score_gemma":0.0004894814,"domain_scores_codex":[0.9996141,0.000134983,0.0000296984,0.00006731897,0.00008781011,0.00006611992],"domain_scores_gemma":[0.9990346,0.000363962,0.0002579502,0.0001284665,0.00006151175,0.0001535957],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"case_report","study_design_scores_codex":[0.01480252,0.001488427,0.5811538,0.0003920766,0.000293135,0.003196138,0.0003901169,0.00103662,0.04294159,0.0002890233,0.004038662,0.3499779],"study_design_scores_gemma":[0.002211636,0.02498107,0.9237553,0.00006187442,0.0002963462,0.02006969,0.0001531938,0.002117982,0.01409644,0.0004339207,0.01180379,0.00001871946],"study_design_candidate":"case_report","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951657,0.002334592,0.000686977,0.0001071235,0.000009931398,0.00006237364,0.000187631,0.00003967947,0.001406067],"genre_scores_gemma":[0.999104,0.000206156,0.00008181992,0.00007054879,0.0000163261,0.00001869979,0.0002446109,0.000003780325,0.0002540918],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002082449,"threshold_uncertainty_score":0.006966472,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2515380104","doi":"10.1002/hon.2339","title":"Training improves the interobserver agreement of the expert positron emission tomography review panel in primary mediastinal B‐cell lymphoma: interim analysis in the ongoing International Extranodal Lymphoma Study Group‐37 study","year":2016,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Cancer Research UK; National Cancer Institute; National Cancer Research Institute","keywords":"Medicine; Concordance; Positron emission tomography; Lymphoma; Nuclear medicine; Radiology; Radiation therapy; Interim; Clinical endpoint; Mediastinum; Clinical trial; Medical physics; Internal medicine","authors":[{"name":"Luca Ceriani","is_ca":false},{"name":"Sally F. Barrington","is_ca":false},{"name":"Alberto Biggi","is_ca":false},{"name":"Bogdan Małkowski","is_ca":false},{"name":"Ur Metser","is_ca":true},{"name":"Annibale Versari","is_ca":false},{"name":"Maurizio Martelli","is_ca":false},{"name":"Andrew Davies","is_ca":false},{"name":"Peter Johnson","is_ca":false},{"name":"Emanuele Zucca","is_ca":false},{"name":"Stéphane Chauvie","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.110996917102976,"gpt":0.3821411964883498,"spread":0.2711442793853738,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.19677,0.0007069134,0.001630475,0.001069555,0.001059215,0.002266091,0.00189503,0.001872986,0.001282189],"category_scores_gemma":[0.2628562,0.001120029,0.003055715,0.001034742,0.0008913072,0.001576215,0.002127858,0.001679759,0.0007078599],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009100231,"about_ca_system_score_gemma":0.001381919,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001712789,"about_ca_topic_score_gemma":0.002150511,"domain_scores_codex":[0.7867473,0.176876,0.01268679,0.01026406,0.0111187,0.002307124],"domain_scores_gemma":[0.576581,0.271164,0.06798422,0.04715328,0.03279031,0.004327125],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05015656,0.001246585,0.8652378,0.0007248077,0.005245355,0.0002084512,0.003793216,0.003180822,0.002830819,0.0002286589,0.005279341,0.06186756],"study_design_scores_gemma":[0.001962162,0.008288772,0.9634576,0.0002443106,0.003380819,0.0003552726,0.000594473,0.01090103,0.004799459,0.0004082581,0.005449103,0.0001587314],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9757504,0.00348963,0.01228659,0.0008988265,0.0006484713,0.00137536,0.000877603,0.0002735672,0.004399496],"genre_scores_gemma":[0.9922566,0.0001340151,0.005137457,0.0003236722,0.0001501409,0.0005720643,0.0008011904,0.00006738974,0.0005574503],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.80323,"threshold_uncertainty_score":0.9905256,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3158953552","doi":"10.1002/hon.2875","title":"Safety and efficacy of autologous whole cell vaccines in hematologic malignancies: A systematic review and meta‐analysis","year":2021,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Ottawa Hospital; Western University","funders":"Ottawa Hospital Anesthesia Alternate Funds Association; Ottawa Hospital; University of Ottawa; Terry Fox Research Institute; Cancer Research Society; American Society of Hematology","keywords":"Medicine; Adverse effect; Internal medicine; Clinical trial; Vaccination; Oncology; Meta-analysis; Immunology","authors":[{"name":"Donald Bastin","is_ca":true},{"name":"S. Khan","is_ca":true},{"name":"Joshua Montroy","is_ca":true},{"name":"Michael A. Kennedy","is_ca":true},{"name":"Nicole Forbes","is_ca":true},{"name":"Andre B. Martel","is_ca":true},{"name":"Laura Baker","is_ca":true},{"name":"Louise Gresham","is_ca":true},{"name":"Dominique Boucher","is_ca":true},{"name":"Boaz Wong","is_ca":true},{"name":"Risa Shorr","is_ca":true},{"name":"Jean‐Simon Diallo","is_ca":true},{"name":"Dean Fergusson","is_ca":true},{"name":"Manoj M. Lalu","is_ca":true},{"name":"Rebecca C. Auer","is_ca":true},{"name":"Natasha Kekre","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04563399071705088,"gpt":0.3339401710395105,"spread":0.2883061803224596,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01157606,0.002162162,0.01656607,0.00634332,0.0005769561,0.002892704,0.001932032,0.001973583,0.003666561],"category_scores_gemma":[0.02861675,0.001335527,0.03043953,0.007830994,0.0007045661,0.001596753,0.001255632,0.001563856,0.0003139958],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002388991,"about_ca_system_score_gemma":0.003698303,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00679569,"about_ca_topic_score_gemma":0.01409727,"domain_scores_codex":[0.9916108,0.003515005,0.002836177,0.0008319656,0.0009592939,0.0002467736],"domain_scores_gemma":[0.9761421,0.01785874,0.003603874,0.0005531439,0.001590569,0.0002515694],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001177622,0.00001864446,0.003138306,0.5868854,0.3970518,0.0001078099,0.00007290745,0.0004747358,0.0001972081,0.0001154541,0.0006425111,0.01011759],"study_design_scores_gemma":[0.00042293,0.0001807921,0.003949948,0.04739458,0.9452352,0.0001109544,0.00005335096,0.0001933941,0.0001293756,0.0001845444,0.002119838,0.00002502973],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003969778,0.9942251,0.0004182497,0.0001566793,0.00008296419,0.0002344537,0.0006726232,0.000018658,0.0002215575],"genre_scores_gemma":[0.1292686,0.8658132,0.001659323,0.0007626356,0.0001875228,0.001035709,0.0009549929,0.00002675103,0.0002912041],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01656607,"threshold_uncertainty_score":0.06122077,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4380078597","doi":"10.1002/hon.3196_lba4","title":"TRANSCEND FL: PHASE 2 STUDY RESULTS OF LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Refractory (planetary science); Follicular lymphoma; Gastroenterology; Clinical endpoint; Oncology; Rituximab; Phases of clinical research; Neutropenia; Lymphoma; Surgery; Clinical trial; Chemotherapy","authors":[{"name":"Franck Morschhauser","is_ca":false},{"name":"Saurabh Dahiya","is_ca":false},{"name":"M. Lia Palomba","is_ca":false},{"name":"Juan Luis Reguera Ortega","is_ca":false},{"name":"John Kuruvilla","is_ca":true},{"name":"Ulrich Jäger","is_ca":false},{"name":"Guillaume Cartron","is_ca":false},{"name":"Koji Izutsu","is_ca":false},{"name":"Martin Dreyling","is_ca":false},{"name":"Brad S. Kahl","is_ca":false},{"name":"Hervé Ghesquières","is_ca":false},{"name":"Kirit M. Ardeshna","is_ca":false},{"name":"Hideki Goto","is_ca":false},{"name":"Anna Maria Barbui","is_ca":false},{"name":"Jeremy S. Abramson","is_ca":false},{"name":"Peter Borchmann","is_ca":false},{"name":"Isabelle Fleury","is_ca":true},{"name":"Stephan Mielke","is_ca":false},{"name":"Thalia A. Farazi","is_ca":false},{"name":"Omotayo Fasan","is_ca":false},{"name":"James Lymp","is_ca":false},{"name":"Min Vedal","is_ca":false},{"name":"Ryuichi Nishii","is_ca":false},{"name":"Ariel Avilion","is_ca":false},{"name":"J. Papuga","is_ca":false},{"name":"Loretta J. Nastoupil","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02644501582058063,"gpt":0.3272590848480463,"spread":0.3008140690274657,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00168515,0.001047184,0.0009372025,0.0002769273,0.000224104,0.0008783487,0.0007081064,0.000917435,0.005394869],"category_scores_gemma":[0.0007670205,0.0003460911,0.001197689,0.0002029748,0.0004399006,0.000623097,0.0003924611,0.001980939,0.001173803],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005723734,"about_ca_system_score_gemma":0.0007625184,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003834367,"about_ca_topic_score_gemma":0.00127638,"domain_scores_codex":[0.9997334,0.0001277612,0.00001276051,0.00004923063,0.00003542248,0.00004141454],"domain_scores_gemma":[0.999588,0.00006944283,0.0001173949,0.00003262144,0.0000401244,0.0001524387],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6027034,0.03660038,0.01535466,0.002767577,0.003318719,0.0004921399,0.0004010836,0.0032529,0.0923029,0.0005990104,0.01685691,0.2253503],"study_design_scores_gemma":[0.4967419,0.4329006,0.0289112,0.0002378419,0.002779027,0.001381912,0.0001243928,0.001807115,0.01392082,0.0005222034,0.0206029,0.00007016615],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9733891,0.009009861,0.001534623,0.001047801,0.000180141,0.003026518,0.005457252,0.0003256484,0.006029089],"genre_scores_gemma":[0.9743599,0.00362648,0.002335733,0.001546155,0.0002238606,0.002725126,0.009723932,0.0001017655,0.005357108],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005394869,"threshold_uncertainty_score":0.01804763,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2128518863","doi":"10.1002/hon.2265","title":"Associations between statin use and non‐Hodgkin lymphoma (NHL) risk and survival: a meta‐analysis","year":2015,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"CancerCare Manitoba; University of Manitoba; Winnipeg Regional Health Authority","funders":"Research Manitoba","keywords":"Medicine; Internal medicine; Hazard ratio; Statin; Lymphoma; Odds ratio; Non-Hodgkin's lymphoma; Meta-analysis; Oncology; Incidence (geometry); Epidemiology; Confidence interval","authors":[{"name":"Xibiao Ye","is_ca":true},{"name":"Ayat Mneina","is_ca":true},{"name":"James B. Johnston","is_ca":true},{"name":"Salaheddin M. Mahmud","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1279351761986888,"gpt":0.3888846451250296,"spread":0.2609494689263407,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008313042,0.002084385,0.01176092,0.003714484,0.0005730328,0.002611795,0.001367418,0.001723473,0.003388161],"category_scores_gemma":[0.01900354,0.001231762,0.03274131,0.004901178,0.0004956037,0.001178865,0.001119546,0.00161372,0.0003009651],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001759087,"about_ca_system_score_gemma":0.001945226,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006635151,"about_ca_topic_score_gemma":0.01326569,"domain_scores_codex":[0.9952077,0.002330887,0.001285462,0.000542776,0.0004229238,0.0002102106],"domain_scores_gemma":[0.9904888,0.006846456,0.001425744,0.0003701761,0.0007115505,0.0001572958],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.003537581,0.00003761833,0.009902111,0.1524453,0.8205606,0.0001915649,0.00006180302,0.0007170388,0.0003018513,0.0001079379,0.0006766148,0.01146003],"study_design_scores_gemma":[0.0004158893,0.0001836512,0.006230234,0.007015811,0.9844919,0.00008940804,0.00002406768,0.0002142075,0.0001153179,0.0001504636,0.001053273,0.00001586976],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01349441,0.9844649,0.0005748718,0.0002504409,0.0001631997,0.0001687072,0.0005464921,0.00002645623,0.000310456],"genre_scores_gemma":[0.3487445,0.6455536,0.002162957,0.0009302293,0.0003320761,0.0006339413,0.001025916,0.00003406746,0.0005827083],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01176092,"threshold_uncertainty_score":0.04396409,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4380078644","doi":"10.1002/hon.3163_5","title":"NIVOLUMAB(N)‐AVD IMPROVES PROGRESSION‐FREE SURVIVAL COMPARED TO BRENTUXIMAB VEDOTIN(BV)‐AVD IN ADVANCED STAGE (AS) CLASSIC HODGKIN LYMPHOMA (HL): RESULTS OF SWOG S1826","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"SickKids Foundation; Princess Margaret Cancer Centre; Hospital for Sick Children; McGill University Health Centre","funders":"National Cancer Institute; Agenzia Italiana del Farmaco, Ministero della Salute; National Institutes of Health; Seagen; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Brentuximab vedotin; Neutropenia; Clinical endpoint; Oncology; Progression-free survival; Phases of clinical research; Randomized controlled trial; Chemotherapy; Lymphoma; Hodgkin lymphoma","authors":[{"name":"Alex F. Herrera","is_ca":false},{"name":"Michael LeBlanc","is_ca":false},{"name":"Sharon M. Castellino","is_ca":false},{"name":"Huilin Li","is_ca":false},{"name":"Sarah C. Rutherford","is_ca":false},{"name":"Andrew M. Evens","is_ca":false},{"name":"Kelly Davison","is_ca":true},{"name":"Angela Punnett","is_ca":true},{"name":"David Hodgson","is_ca":true},{"name":"Susan K. Parsons","is_ca":false},{"name":"Sairah Ahmed","is_ca":false},{"name":"Carla Casulo","is_ca":false},{"name":"Nancy L. Bartlett","is_ca":false},{"name":"Joseph M. Tuscano","is_ca":false},{"name":"Matthew Mei","is_ca":false},{"name":"Brian Hess","is_ca":false},{"name":"Ryan Jacobs","is_ca":false},{"name":"Hayder Saeed","is_ca":false},{"name":"Pallawi Torka","is_ca":false},{"name":"Boyu Hu","is_ca":false},{"name":"Craig H. Moskowitz","is_ca":false},{"name":"Simran Kaur","is_ca":false},{"name":"Gaurav Goyal","is_ca":false},{"name":"Christopher J. Forlenza","is_ca":false},{"name":"Andrew Doan","is_ca":false},{"name":"Adam J. Lamble","is_ca":false},{"name":"Pankaj Kumar","is_ca":false},{"name":"S. Chowdhury","is_ca":false},{"name":"Brett T. Brinker","is_ca":false},{"name":"Neeti Sharma","is_ca":false},{"name":"Anurag K. Singh","is_ca":false},{"name":"Kristie A. Blum","is_ca":false},{"name":"Anamarija M. Perry","is_ca":false},{"name":"Alexandra E. Kovach","is_ca":false},{"name":"Louis S. Constine","is_ca":false},{"name":"Laura Shields","is_ca":false},{"name":"Anca Prica","is_ca":true},{"name":"Richard F. Little","is_ca":false},{"name":"Margaret A. Shipp","is_ca":false},{"name":"Michael Crump","is_ca":true},{"name":"Brad S. Kahl","is_ca":false},{"name":"John P. Leonard","is_ca":false},{"name":"Sonali M. Smith","is_ca":false},{"name":"Joo Y. Song","is_ca":false},{"name":"Kara M. Kelly","is_ca":false},{"name":"Jonathan W. Friedberg","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0415212648976049,"gpt":0.3670687384005554,"spread":0.3255474735029505,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009850726,0.0005104552,0.0008542178,0.0001840427,0.0001703675,0.0005376452,0.0004331518,0.0003968104,0.00201868],"category_scores_gemma":[0.0006714887,0.0002147544,0.0007942981,0.0001751971,0.0003786301,0.0003856682,0.0001790893,0.001211468,0.0003226985],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005517537,"about_ca_system_score_gemma":0.0006576314,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007368483,"about_ca_topic_score_gemma":0.002106504,"domain_scores_codex":[0.9997875,0.0001105834,0.00001521505,0.00003064645,0.00002144862,0.00003460864],"domain_scores_gemma":[0.9995841,0.00009889923,0.0001060908,0.00002504072,0.00002663889,0.0001591782],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.694545,0.02465265,0.01559302,0.00137111,0.001633574,0.0001072519,0.0002901667,0.004143887,0.0363907,0.0002390906,0.007475016,0.2135586],"study_design_scores_gemma":[0.2759719,0.636235,0.06259931,0.0002325524,0.001967444,0.0005023348,0.0001530695,0.004161322,0.009621664,0.0003990639,0.008102597,0.00005372093],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957615,0.002737555,0.00009826596,0.0001887517,0.00006550596,0.0001283406,0.0003407539,0.000033578,0.0006458752],"genre_scores_gemma":[0.9962338,0.001572043,0.0003484819,0.0002602478,0.00006714817,0.000128447,0.0005412119,0.00001108108,0.0008376053],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00201868,"threshold_uncertainty_score":0.006753206,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2411200550","doi":"10.1002/hon.2305","title":"<i>FCGR3A</i>/<i>2A</i> polymorphisms and diffuse large B‐cell lymphoma outcome treated with immunochemotherapy: a meta‐analysis on 1134 patients from two prospective cohorts","year":2016,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Fondation de France; National Cancer Institute; Fondation Philippe Wiener - Maurice Anspach","keywords":"Medicine; Internal medicine; Rituximab; Hazard ratio; Oncology; Single-nucleotide polymorphism; Lymphoma; Diffuse large B-cell lymphoma; Immunology; Genotype; Confidence interval; Biology; Gene; Genetics","authors":[{"name":"Hervé Ghesquières","is_ca":false},{"name":"Beth R. Larrabee","is_ca":false},{"name":"Corinne Haïoun","is_ca":false},{"name":"Brian K. Link","is_ca":false},{"name":"Aurélie Verney","is_ca":false},{"name":"Susan L. Slager","is_ca":false},{"name":"Nicolas Ketterer","is_ca":false},{"name":"Stephen M. Ansell","is_ca":false},{"name":"Richard Delarue","is_ca":false},{"name":"Matthew J. Maurer","is_ca":false},{"name":"Olivier Fitoussi","is_ca":false},{"name":"Thomas M. Habermann","is_ca":false},{"name":"Frédéric Peyrade","is_ca":false},{"name":"Ahmet Doǧan","is_ca":false},{"name":"Thierry Jo Molina","is_ca":false},{"name":"Anne J. Novak","is_ca":false},{"name":"Hervé Tilly","is_ca":false},{"name":"James R. Cerhan","is_ca":false},{"name":"Gilles Salles","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04268589500698621,"gpt":0.3397128301533769,"spread":0.2970269351463907,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007286321,0.00212918,0.006694141,0.00173224,0.0006323429,0.002183042,0.001375699,0.001775437,0.001836589],"category_scores_gemma":[0.008321278,0.001130028,0.03100248,0.003443233,0.0005065558,0.0006613911,0.001010053,0.002115349,0.0002374813],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009747234,"about_ca_system_score_gemma":0.0008078395,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007726031,"about_ca_topic_score_gemma":0.008167725,"domain_scores_codex":[0.9945031,0.002956821,0.0007714872,0.001096005,0.0003804859,0.0002921585],"domain_scores_gemma":[0.9930039,0.004856597,0.001020431,0.0005721351,0.0003363052,0.0002106544],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.01429083,0.00006192426,0.06787012,0.007952265,0.9012653,0.0002201669,0.00006106657,0.001379883,0.0008291659,0.00009530075,0.0006471817,0.005326845],"study_design_scores_gemma":[0.001332825,0.0003485912,0.03766793,0.000504242,0.9579443,0.0001018932,0.00003152611,0.0008922738,0.0001983381,0.0001579856,0.0008024233,0.00001763249],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.394417,0.5960525,0.003222676,0.0009698917,0.000597824,0.0001919716,0.003192331,0.000142448,0.001213321],"genre_scores_gemma":[0.9639612,0.03181138,0.001101543,0.0006039207,0.0002079943,0.000173848,0.001684292,0.00004901384,0.0004067845],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007726031,"threshold_uncertainty_score":0.03853422,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3125135564","doi":"10.1002/hon.2838","title":"Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced‐stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high‐risk patients from the ECHELON‐1 study","year":2021,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; Spinal Cord Injury BC; BC Cancer Agency","funders":"Takeda Oncology","keywords":"Medicine; Dacarbazine; ABVD; Internal medicine; Neutropenia; Brentuximab vedotin; Hazard ratio; Vinblastine; Gastroenterology; Population; Febrile neutropenia; Subgroup analysis; Adverse effect; Surgery; Lymphoma; Oncology; Confidence interval; Chemotherapy; Vincristine; Hodgkin lymphoma; Cyclophosphamide","authors":[{"name":"Martin Hutchings","is_ca":false},{"name":"John Radford","is_ca":false},{"name":"Stephen M. Ansell","is_ca":false},{"name":"Árpád Illés","is_ca":false},{"name":"Anna Sureda","is_ca":false},{"name":"Joseph M. Connors","is_ca":true},{"name":"Alice Šýkorová","is_ca":false},{"name":"Hirohiko Shibayama","is_ca":false},{"name":"Jeremy S. Abramson","is_ca":false},{"name":"Neil Chua","is_ca":true},{"name":"Jonathan W. Friedberg","is_ca":false},{"name":"Jan Kořen","is_ca":false},{"name":"Ann S. LaCasce","is_ca":false},{"name":"Lysiane Molina","is_ca":false},{"name":"Gerald Engley","is_ca":false},{"name":"Keenan Fenton","is_ca":false},{"name":"Hina Jolin","is_ca":false},{"name":"Rachael Liu","is_ca":false},{"name":"Ashish Gautam","is_ca":false},{"name":"Andrea Gallamini","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0133778787264279,"gpt":0.2685635926708242,"spread":0.2551857139443963,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001712374,0.0005138426,0.001449327,0.0004222128,0.0001641133,0.0006320757,0.0003032644,0.000405967,0.0004899052],"category_scores_gemma":[0.001236771,0.0002658698,0.002404856,0.0004756099,0.0002004228,0.0004324657,0.0003521293,0.0006050187,0.00008287943],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003724189,"about_ca_system_score_gemma":0.0004188514,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008230731,"about_ca_topic_score_gemma":0.002722675,"domain_scores_codex":[0.9992672,0.0003587116,0.00008235266,0.0001138758,0.00008490322,0.00009306308],"domain_scores_gemma":[0.9992281,0.0002279234,0.0002248441,0.0001221714,0.00004545336,0.0001513858],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2306993,0.00152481,0.6847858,0.0005445342,0.01643735,0.0004526202,0.0002944642,0.002586416,0.01198714,0.0001156885,0.001030609,0.04954127],"study_design_scores_gemma":[0.03251093,0.03235678,0.9125444,0.00008686184,0.01237549,0.0008330156,0.0002975295,0.004228011,0.002216621,0.0003574356,0.002135211,0.00005779187],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983725,0.001190559,0.00006992991,0.0000328731,0.00001102356,0.00003191102,0.0001568798,0.000002879657,0.0001313687],"genre_scores_gemma":[0.9989611,0.0002873466,0.00008638397,0.00005360286,0.00002862087,0.00002654587,0.0004592602,0.000002117619,0.00009505127],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001712374,"threshold_uncertainty_score":0.009055972,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2164571519","doi":"10.1002/hon.2251","title":"Concomitant high expression of Toll‐like receptor (TLR) and B‐cell receptor (BCR) signalling molecules has clinical implications in mantle cell lymphoma","year":2015,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Calgary Laboratory Services; University of Alberta; Alberta Cancer Foundation; University of Calgary","funders":"Alberta Cancer Foundation; Calgary Laboratory Services","keywords":"breakpoint cluster region; Cancer research; Syk; Biology; B-cell receptor; Mantle cell lymphoma; Toll-like receptor; Signal transduction; TLR7; Bruton's tyrosine kinase; TLR9; Receptor; Immunology; B cell; Gene expression; Cell biology; Innate immune system; Immune system; Gene; Lymphoma; Genetics; Tyrosine kinase; Antibody","authors":[{"name":"Ariz Akhter","is_ca":true},{"name":"Lesley Street","is_ca":true},{"name":"Sunita Ghosh","is_ca":true},{"name":"Bruce F. Burns","is_ca":true},{"name":"Ghaleb Elyamany","is_ca":false},{"name":"Meer‐Taher Shabani‐Rad","is_ca":true},{"name":"Douglas A. Stewart","is_ca":true},{"name":"Adnan Mansoor","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08521364045476884,"gpt":0.3416249336855472,"spread":0.2564112932307784,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001745022,0.0001357667,0.0001637098,0.0003593329,0.0001664203,0.0003137462,0.00007978546,0.0002016147,0.001654327],"category_scores_gemma":[0.0002757519,0.00007781714,0.0001215805,0.0003468458,0.0001894609,0.0001142718,0.0002104207,0.0002710008,0.0002439066],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001357008,"about_ca_system_score_gemma":0.00006948889,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002639148,"about_ca_topic_score_gemma":0.0002568227,"domain_scores_codex":[0.9998552,0.00003052039,0.00001078162,0.00003484753,0.00002769484,0.00004104073],"domain_scores_gemma":[0.9998083,0.00004881903,0.00006937737,0.00001639984,0.00001579743,0.00004133951],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.001588956,0.0001142429,0.2855743,0.0001406581,0.00005991543,0.0005531712,0.0001970789,0.0005430687,0.6947483,0.0001338073,0.0002560843,0.01609045],"study_design_scores_gemma":[0.00002587967,0.0006565985,0.9329234,0.00001329283,0.00006169728,0.002084345,0.0002992035,0.001513948,0.06055477,0.0002926309,0.001565574,0.000008793551],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9987802,0.0003215617,0.000387433,0.00001947422,0.000002058748,0.00000625149,0.0001564253,0.000009739499,0.0003167747],"genre_scores_gemma":[0.999428,0.0000524296,0.0001983899,0.00001124115,0.000003033593,0.000007614184,0.0001550825,0.000001391136,0.0001427938],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001654327,"threshold_uncertainty_score":0.005534291,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2622897264","doi":"10.1002/hon.2437_57","title":"DYNAMO: a PHASE 2 STUDY DEMONSTRATING THE CLINICAL ACTIVITY OF DUVELISIB IN PATIENTS WITH DOUBLE‐REFRACTORY INDOLENT NON‐HODGKIN LYMPHOMA","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Cégep de l'Outaouais; Jewish General Hospital","funders":"","keywords":"Medicine; Internal medicine; Adverse effect; Refractory (planetary science); Gastroenterology; Clinical endpoint; Regimen; Lymphoma; Surgery; Oncology; Clinical trial","authors":[{"name":"Pier Luigi Zinzani","is_ca":false},{"name":"Nina D. Wagner‐Johnston","is_ca":false},{"name":"Carole B. Miller","is_ca":false},{"name":"Kirit M. Ardeshna","is_ca":false},{"name":"S. Tertreault","is_ca":false},{"name":"Sarit Assouline","is_ca":true},{"name":"Jiřı́ Mayer","is_ca":false},{"name":"Francesco Passamonti","is_ca":false},{"name":"Scott D. Lunin","is_ca":false},{"name":"Andrew R. Pettitt","is_ca":false},{"name":"Zsolt Nagy","is_ca":false},{"name":"Olivier Tournilhac","is_ca":false},{"name":"Karim Abou-Nassar","is_ca":true},{"name":"Michael Crump","is_ca":true},{"name":"E. Jacobsen","is_ca":false},{"name":"Sven de Vos","is_ca":false},{"name":"Hagop Youssoufian","is_ca":false},{"name":"Jane Porter","is_ca":false},{"name":"Ian W. Flinn","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08567979818774954,"gpt":0.4524975538175632,"spread":0.3668177556298137,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001103248,0.0006436461,0.001123355,0.0002897909,0.0002088443,0.0006911847,0.0004619441,0.0004576845,0.002000412],"category_scores_gemma":[0.0004629898,0.0003342544,0.0005204441,0.0002457364,0.0004340624,0.000379192,0.0002862555,0.00105568,0.0003806852],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005108921,"about_ca_system_score_gemma":0.0008356972,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005762057,"about_ca_topic_score_gemma":0.00164131,"domain_scores_codex":[0.9998337,0.00007369569,0.00001095129,0.00002616016,0.00002064017,0.00003484472],"domain_scores_gemma":[0.9996665,0.0000555626,0.00006289862,0.00002476633,0.00002026484,0.0001700835],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.521237,0.06034306,0.02734604,0.002391586,0.001592731,0.0006683402,0.0005904171,0.002299444,0.1224254,0.0003906554,0.005169034,0.2555464],"study_design_scores_gemma":[0.5551242,0.382891,0.04101427,0.00007584406,0.000620405,0.001236957,0.0001374247,0.00177324,0.008855373,0.000150246,0.008072619,0.00004830827],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947951,0.002253381,0.0003735267,0.000162375,0.00004610318,0.0007842572,0.0004279984,0.00007852024,0.001078727],"genre_scores_gemma":[0.9931329,0.001513319,0.001019194,0.0003722428,0.00006189207,0.0009174064,0.001423297,0.00001803905,0.001541701],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002000412,"threshold_uncertainty_score":0.006692052,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3178904653","doi":"10.1002/hon.2898","title":"Comparing the safety and efficacy of ruxolitinib in patients with Dynamic International Prognostic Scoring System low‐, intermediate‐1‐, intermediate‐2‐, and high‐risk myelofibrosis in JUMP, a Phase 3b, expanded‐access study","year":2021,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; St. Paul's Hospital; Princess Margaret Cancer Centre","funders":"Novartis Pharma; Celgene","keywords":"Ruxolitinib; International Prognostic Scoring System; Medicine; Myelofibrosis; Internal medicine; Adverse effect; Anemia; Clinical endpoint; Janus kinase inhibitor; Gastroenterology; Surgery; Clinical trial; Bone marrow; Janus kinase; Myelodysplastic syndromes","authors":[{"name":"Francesco Passamonti","is_ca":false},{"name":"Vikas Gupta","is_ca":true},{"name":"Bruno Martino","is_ca":false},{"name":"Lynda Foltz","is_ca":true},{"name":"Andrey Zaritskey","is_ca":false},{"name":"Haifa Kathrin Al‐Ali","is_ca":false},{"name":"Renato Tavares Daher","is_ca":false},{"name":"Margherita Maffioli","is_ca":false},{"name":"Pia Raanani","is_ca":false},{"name":"Pilar Giraldo","is_ca":false},{"name":"Martin Grießhammer","is_ca":false},{"name":"Paola Guglielmelli","is_ca":false},{"name":"Catherine Bouard","is_ca":false},{"name":"Carole Paley","is_ca":false},{"name":"Ranjan Tiwari","is_ca":false},{"name":"Alessandro M. Vannucchi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02074939354465334,"gpt":0.3252005367022574,"spread":0.3044511431576041,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001642833,0.0004026,0.0008321179,0.0002764893,0.0001891025,0.0005080999,0.0002806617,0.0003721635,0.000903019],"category_scores_gemma":[0.001246033,0.0001806133,0.0009040474,0.0002033975,0.000243046,0.0004629739,0.00031286,0.0008428776,0.0001565442],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004118206,"about_ca_system_score_gemma":0.0004748721,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003636008,"about_ca_topic_score_gemma":0.0009261571,"domain_scores_codex":[0.9995377,0.0001965555,0.00004021479,0.00006386335,0.00008152629,0.00008011818],"domain_scores_gemma":[0.9991358,0.0002444846,0.0002269049,0.0000698108,0.00005591904,0.0002671249],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5352927,0.007252531,0.3592971,0.0002517209,0.002323848,0.0002746584,0.0001745868,0.002044097,0.01295925,0.0002415649,0.001744715,0.07814335],"study_design_scores_gemma":[0.09511513,0.1878905,0.7015341,0.00004610541,0.00166169,0.0007788008,0.0001284362,0.006509299,0.003813699,0.0004771149,0.001987432,0.00005770826],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991571,0.0003117571,0.00007018103,0.00003171333,0.000006508421,0.0000467231,0.0001302606,0.00000485032,0.0002407948],"genre_scores_gemma":[0.9987503,0.0001052214,0.0001012074,0.0000851626,0.00003163473,0.00006369467,0.0006958792,0.000001753722,0.0001650279],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001642833,"threshold_uncertainty_score":0.008688271,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3006286575","doi":"10.1002/hon.2723","title":"Final analysis of a phase 1/2b study of ibrutinib combined with carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma","year":2020,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Carfilzomib; Ibrutinib; Medicine; Dexamethasone; Refractory (planetary science); Multiple myeloma; Oncology; Internal medicine; Lenalidomide; Leukemia; Materials science","authors":[{"name":"Ajai Chari","is_ca":false},{"name":"Robert F. Cornell","is_ca":false},{"name":"Cristina Gasparetto","is_ca":false},{"name":"Chatchada Karanes","is_ca":false},{"name":"Jeffrey Matous","is_ca":false},{"name":"Rubén Niesvizky","is_ca":false},{"name":"Matthew A. Lunning","is_ca":false},{"name":"Saad Z. Usmani","is_ca":false},{"name":"Larry D. Anderson","is_ca":false},{"name":"Saurabh Chhabra","is_ca":false},{"name":"Saulius Girnius","is_ca":false},{"name":"Chaim Shustik","is_ca":true},{"name":"Robert K. Stuart","is_ca":false},{"name":"Yihua Lee","is_ca":false},{"name":"Zeena Salman","is_ca":false},{"name":"Emily Liu","is_ca":false},{"name":"Jason Valent","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06631480899877269,"gpt":0.3511896877632336,"spread":0.2848748787644609,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005692292,0.001859521,0.002818902,0.0006432018,0.0005878726,0.00126684,0.0007497036,0.001195094,0.001961601],"category_scores_gemma":[0.002163246,0.0007521571,0.002805503,0.0005827008,0.0007942197,0.0006859779,0.0004920168,0.002626922,0.0005922091],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001322784,"about_ca_system_score_gemma":0.001949471,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001086845,"about_ca_topic_score_gemma":0.002639574,"domain_scores_codex":[0.9974064,0.001717364,0.0001220773,0.000272217,0.0001874583,0.000294335],"domain_scores_gemma":[0.9984138,0.0003580541,0.0002898162,0.0001493859,0.0001299096,0.0006590699],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7700758,0.06285124,0.02952061,0.0006691577,0.005336222,0.0006565893,0.0004115612,0.003150275,0.05321684,0.0002433747,0.003531824,0.07033643],"study_design_scores_gemma":[0.413271,0.5283682,0.04758287,0.00003857765,0.001761974,0.000334761,0.00007539304,0.001239598,0.003709792,0.0001476583,0.003421671,0.00004845569],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99098,0.001784762,0.0006051637,0.0005867054,0.00009046978,0.003232297,0.001581554,0.00007042301,0.001068699],"genre_scores_gemma":[0.9889144,0.0007677402,0.002215012,0.0009698432,0.0001927129,0.002238723,0.003632171,0.00003144017,0.001037937],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005692292,"threshold_uncertainty_score":0.03010404,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3111005279","doi":"10.1002/hon.2830","title":"Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland","year":2020,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"WiLAN (Canada)","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Confidence interval; Population; Retrospective cohort study; Lymphoma; Surgery","authors":[{"name":"Alden A. Moccia","is_ca":false},{"name":"Stefanie Aeppli","is_ca":false},{"name":"Sabine Güsewell","is_ca":false},{"name":"Mario Bargetzi","is_ca":false},{"name":"Clemens B. Caspar","is_ca":false},{"name":"D. Brülisauer","is_ca":false},{"name":"Monika Ebnöther","is_ca":false},{"name":"Martin Fehr","is_ca":false},{"name":"Natalie Fischer","is_ca":false},{"name":"Guido Ghilardi","is_ca":false},{"name":"Fatime Krasniqi","is_ca":false},{"name":"Noémie Lang","is_ca":false},{"name":"Ulrich Mey","is_ca":false},{"name":"Walter Mingrone","is_ca":false},{"name":"Urban Novak","is_ca":false},{"name":"Claudia Pfleger","is_ca":false},{"name":"P Richter","is_ca":false},{"name":"Markus F. Rütti","is_ca":true},{"name":"Adrian Schmidt","is_ca":false},{"name":"Frank Stenner","is_ca":false},{"name":"Michèle Voegeli","is_ca":false},{"name":"Thilo Zander","is_ca":false},{"name":"Emanuele Zucca","is_ca":false},{"name":"Felicitas Hitz","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05213350040243925,"gpt":0.3476552728913584,"spread":0.2955217724889191,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002520072,0.0001878091,0.0002326846,0.0006811341,0.0002917158,0.000464916,0.0001099935,0.0003139967,0.0009210185],"category_scores_gemma":[0.0006835571,0.0001396936,0.0002336254,0.0005673709,0.0002898164,0.0002946401,0.0003265749,0.0002238942,0.0001801834],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004580626,"about_ca_system_score_gemma":0.0002704057,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007523246,"about_ca_topic_score_gemma":0.008663605,"domain_scores_codex":[0.999818,0.00004111305,0.00002099655,0.000038742,0.00002795209,0.00005321597],"domain_scores_gemma":[0.9994645,0.00009041013,0.0002643592,0.00002325255,0.00004303096,0.0001145596],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00009882434,0.00001981475,0.9986901,0.000004618736,0.00001100724,0.0001034383,0.00007074778,0.00008359005,0.0001606311,0.000005494602,0.00004868126,0.0007031169],"study_design_scores_gemma":[0.000005563976,0.00008637134,0.9993887,0.000003052406,0.000007381397,0.000186896,0.0001348289,0.00006869824,0.00001890216,0.000006386324,0.00009102027,0.00000224337],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9995975,0.0001062196,0.00001572871,0.00001088246,0.000001726937,0.000003243279,0.0001154112,0.000001070346,0.0001481985],"genre_scores_gemma":[0.9995925,0.00005982498,0.0000102597,0.00001222692,0.000005932221,0.00000426488,0.0002603069,5.473125e-7,0.000054052],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007523246,"threshold_uncertainty_score":0.01495892,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4380078158","doi":"10.1002/hon.3163_156","title":"MURANO: Final 7 year follow up and retreatment analysis in venetoclax‐rituximab (VenR)‐treated patients with relapsed/refractory chronic lymphocytic leukemia (<i>R</i>/<i>R</i> CLL)","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital; University of Calgary","funders":"F. Hoffmann-La Roche; AstraZeneca","keywords":"Medicine; Bendamustine; Internal medicine; Hazard ratio; Rituximab; Regimen; Confidence interval; Gastroenterology; Chronic lymphocytic leukemia; Refractory (planetary science); Progression-free survival; Surgery; Leukemia; Overall survival; Lymphoma","authors":[{"name":"Arnon P. Kater","is_ca":false},{"name":"Rosemary Harrup","is_ca":false},{"name":"Thomas J. Kipps","is_ca":false},{"name":"Barbara Eichhorst","is_ca":false},{"name":"Carolyn Owen","is_ca":true},{"name":"Sarit Assouline","is_ca":true},{"name":"Nicole Lamanna","is_ca":false},{"name":"Tadeusz Robak","is_ca":false},{"name":"Javier de la Serna","is_ca":false},{"name":"Ulrich Jaeger","is_ca":false},{"name":"Guillaume Cartron","is_ca":false},{"name":"Marco Montillo","is_ca":false},{"name":"Clemens Mellink","is_ca":false},{"name":"Brenda Chyla","is_ca":false},{"name":"Maria Thadani‐Mulero","is_ca":false},{"name":"Marcus Lefebure","is_ca":false},{"name":"Yanwen Jiang","is_ca":false},{"name":"Rosemary Millen","is_ca":false},{"name":"Michelle Boyer","is_ca":false},{"name":"John F. Seymour","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02797735490506649,"gpt":0.3028320781248924,"spread":0.2748547232198259,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001420502,0.0002939031,0.0008327522,0.0002163752,0.0001974098,0.0005391794,0.0004261471,0.0004029319,0.001353797],"category_scores_gemma":[0.001303929,0.0002057504,0.001000816,0.0002788656,0.0002193619,0.0003587648,0.0003727953,0.0007786675,0.0002441653],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005745375,"about_ca_system_score_gemma":0.0004316266,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001357031,"about_ca_topic_score_gemma":0.002691209,"domain_scores_codex":[0.9995932,0.000182242,0.00002303754,0.00009996216,0.00004272449,0.00005889252],"domain_scores_gemma":[0.9990846,0.0001970811,0.0003724309,0.0001101167,0.00006599988,0.0001698369],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3352375,0.003401515,0.5178567,0.0005979827,0.00372118,0.0004315171,0.0006087465,0.002748724,0.01796846,0.0002438268,0.004469285,0.1127145],"study_design_scores_gemma":[0.02206205,0.05424202,0.9108366,0.00006683685,0.002635898,0.0006295302,0.0001102028,0.002125936,0.002058505,0.0001620902,0.005032978,0.00003731938],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978643,0.0007603874,0.00007654896,0.00005215583,0.00001081525,0.00005990803,0.0006511786,0.000009732582,0.0005149061],"genre_scores_gemma":[0.9966707,0.0001907879,0.0001940354,0.0001065208,0.00002775308,0.0001120423,0.002033256,0.00000533367,0.0006596048],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001420502,"threshold_uncertainty_score":0.007512391,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2527713631","doi":"10.1002/hon.2351","title":"Proteasome inhibitors in AL amyloidosis: focus on mechanism of action and clinical activity","year":2016,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Ministry of Health, British Columbia; Mental Health Association of Westchester County","keywords":"Ixazomib; Bortezomib; Carfilzomib; Amyloidosis; Multiple myeloma; Proteasome inhibitor; Medicine; Proteasome; AL amyloidosis; Pharmacology; Oncology; Cancer research; Internal medicine; Immunoglobulin light chain; Immunology; Chemistry; Biochemistry","authors":[{"name":"Tomáš Jelı́nek","is_ca":false},{"name":"Elena Kryukova","is_ca":false},{"name":"Fedor Kryukov","is_ca":false},{"name":"Roman Hájek","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07908604674415905,"gpt":0.4205617516177201,"spread":0.341475704873561,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006463206,0.0006122846,0.001152626,0.002211055,0.0002266478,0.0008829983,0.000601172,0.0008324824,0.002491612],"category_scores_gemma":[0.0009905527,0.0002143318,0.0006443682,0.001869319,0.0004408354,0.00124885,0.0005298945,0.001946447,0.0009949569],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005422873,"about_ca_system_score_gemma":0.0009142064,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006358393,"about_ca_topic_score_gemma":0.001247212,"domain_scores_codex":[0.9997723,0.00003910879,0.00004970971,0.00004280319,0.00007476701,0.00002141069],"domain_scores_gemma":[0.9995071,0.0002724287,0.00006472111,0.00001248977,0.0001106679,0.00003261914],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000142219,0.00009237958,0.0003700678,0.02003191,0.0001210664,0.0003281739,0.00007686129,0.0004231194,0.001715253,0.002571031,0.02241614,0.9517117],"study_design_scores_gemma":[0.00003617513,0.0002531564,0.001575292,0.00910725,0.00026049,0.003876711,0.00007759374,0.0001466273,0.000822296,0.002366878,0.9814496,0.00002793473],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001100651,0.9990724,0.00005670349,0.0002013879,0.0000908354,0.000001840397,0.00001030037,0.000004163464,0.000452331],"genre_scores_gemma":[0.0007506825,0.9986039,0.0001098648,0.0001550907,0.0001429538,0.000002955837,0.00001853008,0.000001123494,0.0002149569],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002491612,"threshold_uncertainty_score":0.008335292,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3176099878","doi":"10.1002/hon.49_2879","title":"IMPACT OF DIFFERENT INDUCTION REGIMENS ON THE OUTCOME OF PRIMARY MEDIASTINAL B CELL LYMPHOMA IN THE PROSPECTIVE IELSG 37 TRIAL","year":2021,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; St. Thomas Hospital; University Health Network","funders":"Pharmacyclics; Swiss Cancer Research Foundation; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Celltrion; BeiGene; AstraZeneca; Celltrion Healthcare; Gilead Sciences; Celgene; Amgen; Pfizer; Cancer Research UK; Incyte; National Science Foundation","keywords":"Medicine; Clinical endpoint; Regimen; Rituximab; Chemoimmunotherapy; Internal medicine; Oncology; Population; Randomized controlled trial; Lymphoma; Surgery","authors":[{"name":"Maurizio Martelli","is_ca":false},{"name":"Emanuele Zucca","is_ca":false},{"name":"Barbara Botto","is_ca":false},{"name":"Irina Kryachok","is_ca":false},{"name":"Luca Ceriani","is_ca":false},{"name":"Monica Balzarotti","is_ca":false},{"name":"Alessandra Tucci","is_ca":false},{"name":"M. G. Cabras","is_ca":false},{"name":"Vittorio Ruggero Zilioli","is_ca":false},{"name":"C. Rusconi","is_ca":false},{"name":"F. Angrilli","is_ca":false},{"name":"Luca Arcaini","is_ca":false},{"name":"A. Dabrowska Iwanicka","is_ca":false},{"name":"Andrés J.M. Ferreri","is_ca":false},{"name":"Francesco Merli","is_ca":false},{"name":"Weili Zhao","is_ca":false},{"name":"David Hodgson","is_ca":true},{"name":"C Ionescu","is_ca":false},{"name":"Alexander Fosså","is_ca":false},{"name":"Kate Cwynarski","is_ca":false},{"name":"G. Mikhaeel","is_ca":true},{"name":"Mats Jerkeman","is_ca":false},{"name":"Andrea Janíková","is_ca":false},{"name":"Andreas Hüttmann","is_ca":false},{"name":"Giovannino Ciccone","is_ca":false},{"name":"Ur Metser","is_ca":true},{"name":"Sally F. Barrington","is_ca":false},{"name":"Bogdan Małkowski","is_ca":false},{"name":"Annibale Versari","is_ca":false},{"name":"F. Espósito","is_ca":false},{"name":"Kelly Cozens","is_ca":false},{"name":"Nicoletta Ielmini","is_ca":false},{"name":"R. Ricardi","is_ca":false},{"name":"Franco Cavalli","is_ca":false},{"name":"Peter Johnson","is_ca":false},{"name":"Alex Davies","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07152412977678226,"gpt":0.3516985184666783,"spread":0.2801743886898961,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004308029,0.001066224,0.002216101,0.0003123146,0.0002645131,0.001154736,0.0007921483,0.001068886,0.002682016],"category_scores_gemma":[0.0027168,0.0002716268,0.002745894,0.0005159441,0.0007709027,0.0009290157,0.0006865658,0.00228099,0.0004040104],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001080767,"about_ca_system_score_gemma":0.001038642,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004677135,"about_ca_topic_score_gemma":0.001171272,"domain_scores_codex":[0.9982284,0.001026301,0.0001444644,0.0002603593,0.0001340883,0.0002063851],"domain_scores_gemma":[0.9985545,0.0004723639,0.0004061712,0.0002144822,0.00005619338,0.0002962755],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9621366,0.001403172,0.0107463,0.0006291452,0.003249895,0.00006049489,0.00006177258,0.001265828,0.001235265,0.0002227595,0.001023321,0.01796543],"study_design_scores_gemma":[0.7199318,0.175439,0.08028162,0.000584838,0.0123107,0.0002539576,0.000117436,0.002242683,0.002503493,0.001946454,0.00430812,0.00007973949],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9849457,0.008794079,0.0003448086,0.0005582558,0.0001334376,0.0009089896,0.001674816,0.00004092505,0.002599124],"genre_scores_gemma":[0.9910294,0.001551684,0.0004556018,0.0007623414,0.0001717058,0.001412229,0.003412742,0.00002102583,0.001183332],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004308029,"threshold_uncertainty_score":0.02278334,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2621758445","doi":"10.1002/hon.2437_99","title":"INTEGRATED ANALYSIS: OUTCOMES OF IBRUTINIB‐TREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LEUKEMIA (CLL/SLL) WITH HIGH‐RISK PROGNOSTIC FACTORS","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Ibrutinib; Internal medicine; Chronic lymphocytic leukemia; IGHV@; Ofatumumab; Oncology; Chlorambucil; Leukemia; Univariate analysis; Bendamustine; Multivariate analysis; Chemotherapy; Cyclophosphamide","authors":[{"name":"Thomas J. Kipps","is_ca":false},{"name":"Graeme Fraser","is_ca":true},{"name":"Steven Coutré","is_ca":false},{"name":"Jennifer R. Brown","is_ca":false},{"name":"Jacqueline C. Barrientos","is_ca":false},{"name":"Paul M. Barr","is_ca":false},{"name":"John C. Byrd","is_ca":false},{"name":"Susan O’Brien","is_ca":false},{"name":"M.S. Dilhuydy","is_ca":false},{"name":"Peter Hillmen","is_ca":false},{"name":"Ulrich Jaeger","is_ca":false},{"name":"Carol Moreno","is_ca":false},{"name":"Paula Cramer","is_ca":false},{"name":"Stephan Stilgenbauer","is_ca":false},{"name":"A.A. Chanan‐Khan","is_ca":false},{"name":"Michelle Mahler","is_ca":false},{"name":"Mariya Salman","is_ca":false},{"name":"Minghua Cheng","is_ca":false},{"name":"Anil Londhe","is_ca":false},{"name":"Joi Ninomoto","is_ca":false},{"name":"Angela Howes","is_ca":false},{"name":"Danelle F. James","is_ca":false},{"name":"Michael Hallek","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02770539388624377,"gpt":0.2986521199294849,"spread":0.2709467260432412,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002572178,0.0007540229,0.001663872,0.001202577,0.0001767072,0.0008700316,0.0006810277,0.0004411995,0.00245954],"category_scores_gemma":[0.001820202,0.0002037294,0.003863366,0.001285515,0.0001931542,0.0005146423,0.0007922729,0.0005608329,0.0001717043],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007109688,"about_ca_system_score_gemma":0.0007221341,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002118889,"about_ca_topic_score_gemma":0.004216352,"domain_scores_codex":[0.9985126,0.0006565423,0.0001456964,0.0003101715,0.000210628,0.0001643288],"domain_scores_gemma":[0.9985688,0.0004199072,0.0005627321,0.0001049927,0.0001518863,0.0001917018],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1006789,0.000431083,0.8162735,0.001103798,0.03182545,0.0001778696,0.0001328248,0.003030456,0.003912676,0.0001298352,0.001273283,0.04103036],"study_design_scores_gemma":[0.004657729,0.01077257,0.9558385,0.0001284843,0.02061509,0.0003506289,0.0001534883,0.003752443,0.001293485,0.0001943055,0.002206915,0.00003636554],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900274,0.005315806,0.0005700055,0.00008458078,0.00002074766,0.0001053041,0.002947051,0.00001813987,0.0009109523],"genre_scores_gemma":[0.9958609,0.0003774938,0.0002081828,0.00003913419,0.00004441078,0.0000825089,0.0031022,0.000005688131,0.0002796337],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002572178,"threshold_uncertainty_score":0.01360315,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2891861976","doi":"10.1002/hon.2560","title":"Outcome of patients with relapsed or refractory anaplastic large cell lymphoma who have failed brentuximab vedotin","year":2018,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Refractory (planetary science); Anaplastic large-cell lymphoma; Internal medicine; Salvage therapy; Surgery; Gastroenterology; Lymphoma; Chemotherapy; Oncology; CD30","authors":[{"name":"Dai Chihara","is_ca":false},{"name":"Shannon Wong","is_ca":true},{"name":"Tatyana Feldman","is_ca":false},{"name":"Michelle A. Fanale","is_ca":false},{"name":"Larysa Sanchez","is_ca":false},{"name":"Joseph M. Connors","is_ca":true},{"name":"Kerry J. Savage","is_ca":true},{"name":"Yasuhiro Oki","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02367617166302798,"gpt":0.3013416210523374,"spread":0.2776654493893094,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000333424,0.0002636726,0.0005647966,0.0002961778,0.0003352705,0.0004826726,0.0002121192,0.0004520473,0.0006069217],"category_scores_gemma":[0.0009301517,0.0001332956,0.0005894604,0.0002806516,0.0002865408,0.0002743827,0.0002878132,0.0003980279,0.0002414917],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003909386,"about_ca_system_score_gemma":0.000199975,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007423069,"about_ca_topic_score_gemma":0.0008754961,"domain_scores_codex":[0.9998147,0.00005038403,0.00002065005,0.00003174994,0.00002119879,0.00006141646],"domain_scores_gemma":[0.9994279,0.00008773543,0.0001715991,0.00003471385,0.00003940316,0.0002386552],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005285206,0.0004884626,0.9672936,0.00004605416,0.0002189453,0.004539614,0.0003716183,0.001109657,0.004249262,0.00005652923,0.0003631665,0.01597787],"study_design_scores_gemma":[0.0004586233,0.01481208,0.9725465,0.00003198622,0.0002423203,0.008008497,0.0003305075,0.001380605,0.001086633,0.0001191081,0.0009506331,0.00003240555],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.999403,0.0002736725,0.00003634935,0.00002917832,0.000004614603,0.000007174998,0.00005371676,0.000002830257,0.00018944],"genre_scores_gemma":[0.9995463,0.00007313931,0.00002394533,0.00004362286,0.00001156628,0.000007276726,0.0001961424,0.000001432005,0.00009656939],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0007423069,"threshold_uncertainty_score":0.002836406,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4379981441","doi":"10.1002/hon.3164_163","title":"Characterization of Mechanisms of Resistance in Previously Treated Chronic Lymphocytic Leukemia (CLL) From a Head‐to‐Head Trial of Acalabrutinib Versus Ibrutinib","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca","keywords":"Ibrutinib; Bruton's tyrosine kinase; Chronic lymphocytic leukemia; Medicine; Oncology; Progression-free survival; Fludarabine; Cancer research; Internal medicine; Immunology; Leukemia; Tyrosine kinase; Chemotherapy; Receptor","authors":[{"name":"Jennifer A. Woyach","is_ca":false},{"name":"Dan Jones","is_ca":false},{"name":"Wojciech Jurczak","is_ca":false},{"name":"Tadeusz Robak","is_ca":false},{"name":"Árpád Illés","is_ca":false},{"name":"Arnon P. Kater","is_ca":false},{"name":"Paolo Ghia","is_ca":false},{"name":"John C. Byrd","is_ca":false},{"name":"John F. Seymour","is_ca":false},{"name":"Susan K. De Long","is_ca":false},{"name":"Nihal Mohamed","is_ca":false},{"name":"G. De Jesus","is_ca":false},{"name":"Rai‐Hua Lai","is_ca":false},{"name":"Gerjan de Bruin","is_ca":false},{"name":"A Butturini","is_ca":false},{"name":"Simon Rule","is_ca":true},{"name":"Veerendra Munugalavadla","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07190435046110251,"gpt":0.3793572972091509,"spread":0.3074529467480484,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00131531,0.0003216465,0.001020455,0.0003649726,0.0002685123,0.0005492223,0.0003032586,0.0003964538,0.00298158],"category_scores_gemma":[0.0009071697,0.0001620015,0.0004993627,0.0002994025,0.0002668264,0.0003410888,0.0002445096,0.0007446794,0.0003406834],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000545973,"about_ca_system_score_gemma":0.0003953413,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007257907,"about_ca_topic_score_gemma":0.001343106,"domain_scores_codex":[0.9995994,0.0001156291,0.000032506,0.0000854379,0.00007382977,0.00009309543],"domain_scores_gemma":[0.9992831,0.0002224325,0.000150521,0.00007161372,0.00005151177,0.0002208152],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.3059652,0.007924357,0.302471,0.0005340373,0.002362481,0.001344537,0.0007804292,0.002900427,0.1512505,0.0003491845,0.004373187,0.2197446],"study_design_scores_gemma":[0.02490802,0.1783835,0.7665506,0.00006379111,0.001418173,0.002999574,0.0001754024,0.0024129,0.01512134,0.0002820029,0.007642304,0.00004241384],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978728,0.0006715196,0.000100937,0.0000480669,0.000007862248,0.0001020421,0.0004188689,0.00001280365,0.0007650554],"genre_scores_gemma":[0.9971381,0.0001712975,0.0001271359,0.000163852,0.00003586138,0.0001175077,0.001583216,0.00000659109,0.0006562703],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00298158,"threshold_uncertainty_score":0.00997436,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4310179086","doi":"10.1002/hon.3102","title":"The role of Vertebral Augmentation Procedures in the management of vertebral compression fractures secondary to multiple myeloma","year":2022,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Spine and Intervertebral Disc Pathology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Kyphosis; Vertebral body; Bone cement; Vertebral compression fracture; Percutaneous vertebroplasty; Balloon; Surgery; Percutaneous; Radiology; Radiography; Cement","authors":[{"name":"Kelechi Eseonu","is_ca":true},{"name":"Jaykar R. Panchmatia","is_ca":true},{"name":"Matthew Streetly","is_ca":true},{"name":"Jonathan N. Grauer","is_ca":false},{"name":"Bahram Fakouri","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05215859064356804,"gpt":0.3958581806660868,"spread":0.3436995900225188,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007909363,0.0002844732,0.0008441182,0.001001666,0.0003387972,0.0007527543,0.0004874588,0.0008605882,0.001757419],"category_scores_gemma":[0.002051981,0.0001186327,0.0007396808,0.0007038715,0.0004482286,0.0004348848,0.0003881917,0.001226937,0.0003524255],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004581784,"about_ca_system_score_gemma":0.001033914,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001573436,"about_ca_topic_score_gemma":0.002897691,"domain_scores_codex":[0.9995264,0.0001385593,0.00007056139,0.00004802544,0.0001846848,0.00003179535],"domain_scores_gemma":[0.9990939,0.0005202797,0.0001929178,0.00001678021,0.000131879,0.00004427253],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003420153,0.00008783842,0.001774672,0.010947,0.0002790443,0.001062869,0.0001670496,0.00039888,0.00172261,0.001238814,0.004742499,0.9772367],"study_design_scores_gemma":[0.0003426223,0.003690726,0.06087396,0.04663954,0.002112038,0.05718591,0.0009155091,0.0009993454,0.004201023,0.00765332,0.8152576,0.0001283189],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002403198,0.9950427,0.0002410662,0.000679317,0.000114108,0.000007204641,0.00001608224,0.000009161774,0.001487206],"genre_scores_gemma":[0.03210619,0.9646958,0.001261681,0.0006927299,0.0006791651,0.000019363,0.00006420843,0.000006492636,0.0004743806],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001757419,"threshold_uncertainty_score":0.005879104,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2623202484","doi":"10.1002/hon.2437_130","title":"FIRST‐LINE TREATMENT OF INHL OR MCL PATIENTS WITH BR OR R‐CHOP/R‐CVP: RESULTS OF THE BRIGHT 5‐YEAR FOLLOW‐UP STUDY","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Ottawa Hospital","funders":"","keywords":"Medicine; Rituximab; Vincristine; Prednisone; CHOP; Internal medicine; Hazard ratio; Gastroenterology; Mantle cell lymphoma; Cyclophosphamide; Confidence interval; Lymphoma; Surgery; Oncology; Chemotherapy","authors":[{"name":"Ian W. Flinn","is_ca":false},{"name":"Richard van der Jagt","is_ca":true},{"name":"Julie Chang","is_ca":false},{"name":"Peter Wood","is_ca":false},{"name":"T Hawkins","is_ca":false},{"name":"David MacDonald","is_ca":true},{"name":"Judith Trotman","is_ca":false},{"name":"David Simpson","is_ca":false},{"name":"Kathryn S. Kolibaba","is_ca":false},{"name":"Samar Issa","is_ca":false},{"name":"Doreen M. Hallman","is_ca":false},{"name":"L. Chen","is_ca":false},{"name":"John M. Burke","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06503796508252431,"gpt":0.3461452574412059,"spread":0.2811072923586816,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004198502,0.0006441962,0.002016963,0.0003767354,0.0003916354,0.0009586648,0.0007716237,0.0009930539,0.001627746],"category_scores_gemma":[0.001670555,0.000464963,0.001927651,0.0003357487,0.0006098403,0.0007467449,0.0004184954,0.002076461,0.0004501579],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009039513,"about_ca_system_score_gemma":0.000742249,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000591449,"about_ca_topic_score_gemma":0.001131638,"domain_scores_codex":[0.9983732,0.0008941385,0.00009036087,0.000209179,0.0002305306,0.000202591],"domain_scores_gemma":[0.9980351,0.0003896981,0.0006816904,0.0002389173,0.0001091364,0.0005453804],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7966447,0.02700454,0.07477051,0.0006291405,0.005511945,0.0001995139,0.0002169241,0.000842254,0.008972189,0.0001082033,0.002220689,0.08287942],"study_design_scores_gemma":[0.3854088,0.3507878,0.2523952,0.0001327355,0.003885154,0.0004774857,0.0001102332,0.001296913,0.002547008,0.0001670398,0.002729597,0.00006202455],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956944,0.002800696,0.0001710615,0.0001169008,0.00004064168,0.0002451722,0.0004842702,0.00002218616,0.000424695],"genre_scores_gemma":[0.9952974,0.0009592048,0.0003183281,0.0005787378,0.00014206,0.0002233238,0.001941227,0.000006913273,0.0005328062],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004198502,"threshold_uncertainty_score":0.0222041,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4319826530","doi":"10.1002/hon.3126","title":"Predictors of ibrutinib‐associated atrial fibrillation: 5‐year follow‐up of a prospective study","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Ministry of Health, British Columbia; Ministero della Salute","keywords":"Ibrutinib; Atrial fibrillation; Medicine; Internal medicine; Cardiology; Prospective cohort study; Cohort; Incidence (geometry); Chronic lymphocytic leukemia; Leukemia","authors":[{"name":"Veronica Mattiello","is_ca":false},{"name":"Angelica Barone","is_ca":false},{"name":"Diana Giannarelli","is_ca":false},{"name":"Alessandro Noto","is_ca":false},{"name":"Nicola Cecchi","is_ca":false},{"name":"Nicolò Rampi","is_ca":false},{"name":"Ramona Cassin","is_ca":false},{"name":"Gianluigi Reda","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0553593713309901,"gpt":0.3744604305517121,"spread":0.319101059220722,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001337718,0.0003292453,0.0004344683,0.0007879726,0.0006060661,0.00103055,0.000354178,0.0006971586,0.001060018],"category_scores_gemma":[0.002436806,0.0003610709,0.0006771171,0.001099604,0.0002695632,0.0007717432,0.0005914932,0.0007432848,0.0003473637],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002712893,"about_ca_system_score_gemma":0.0002773696,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002083033,"about_ca_topic_score_gemma":0.00168607,"domain_scores_codex":[0.9991891,0.000193187,0.0001204373,0.0002243741,0.0001342997,0.0001385936],"domain_scores_gemma":[0.9977229,0.0003564317,0.0008396122,0.0002923011,0.0003247212,0.000464011],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003065352,0.00005157261,0.9984988,0.000004772979,0.00008565342,0.00009617965,0.00005157965,0.00001895322,0.0001297807,0.000006108995,0.00005372198,0.000696452],"study_design_scores_gemma":[0.00002155487,0.0002151005,0.9990321,0.000005798881,0.00007426505,0.0002223173,0.0001107632,0.0001149893,0.00004738028,0.00001108873,0.0001398993,0.00000470446],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9988348,0.0004301413,0.000113566,0.00002567542,0.000006906861,0.00001017583,0.0003753962,0.000002720705,0.0002007975],"genre_scores_gemma":[0.9990553,0.0001190749,0.00004785389,0.00002548393,0.00001169524,0.0000104113,0.0006308935,0.000001864099,0.0000974451],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002083033,"threshold_uncertainty_score":0.007074654,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2604118521","doi":"10.1002/hon.2411","title":"Follicular lymphoma: State‐of‐the‐art ICML workshop in Lugano 2015","year":2017,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"Instituto de Ciencias del Mar y Limnología, Universidad Nacional Autónoma de México; European School of Oncology; Cancer Research UK; American Association for Cancer Research","keywords":"Follicular lymphoma; Epigenetics; Clinical Oncology; Lymphoma; Medicine; Oncology; Internal medicine; Cancer; Biology; Genetics; Gene","authors":[{"name":"Randy D. Gascoyne","is_ca":true},{"name":"Bertrand Nadel","is_ca":false},{"name":"Laura Pasqualucci","is_ca":false},{"name":"Jude Fitzgibbon","is_ca":false},{"name":"Jacqueline E. Payton","is_ca":false},{"name":"Ari Melnick","is_ca":false},{"name":"Oliver Weigert","is_ca":false},{"name":"Karin Tarte","is_ca":false},{"name":"John G. Gribben","is_ca":false},{"name":"Jonathan W. Friedberg","is_ca":false},{"name":"John F. Seymour","is_ca":false},{"name":"Franco Cavalli","is_ca":false},{"name":"Emanuele Zucca","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.128309007466073,"gpt":0.4340798591280272,"spread":0.3057708516619542,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001077507,0.0007785722,0.0006852187,0.001986514,0.0002611627,0.001178117,0.0008233363,0.001216455,0.004814391],"category_scores_gemma":[0.0007456079,0.0002535656,0.000551345,0.001313999,0.0004099653,0.001201936,0.001367094,0.001612625,0.001996508],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00134915,"about_ca_system_score_gemma":0.00154549,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001191513,"about_ca_topic_score_gemma":0.002488233,"domain_scores_codex":[0.9997178,0.00006174113,0.0000355286,0.00004471457,0.00008724841,0.00005303377],"domain_scores_gemma":[0.9997807,0.00006546748,0.00002665475,0.000006557136,0.00006513766,0.00005544053],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001991335,0.00008373139,0.0004000526,0.00886004,0.00005493277,0.001106733,0.0002581636,0.0003806597,0.003442765,0.004802939,0.1623503,0.8180605],"study_design_scores_gemma":[0.0000129059,0.00005467734,0.0007468704,0.003472306,0.00004381497,0.002456818,0.00008365405,0.00005142803,0.0007751861,0.0005570884,0.9917298,0.00001540566],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009382532,0.9851922,0.0004472706,0.002863178,0.004977965,0.00003048707,0.00008640387,0.00003103316,0.005433185],"genre_scores_gemma":[0.007586843,0.9762822,0.0008491509,0.002065366,0.00406479,0.00005377204,0.000400485,0.0000178783,0.008679565],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004814391,"threshold_uncertainty_score":0.01610571,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2073588844","doi":"10.1002/hon.935","title":"Vav‐1 expression correlates with NFκB activation and CD40‐mediated cell death in diffuse large B‐cell lymphoma cell lines","year":2010,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; McGill University and Génome Québec Innovation Centre; Jewish General Hospital","funders":"","keywords":"Germinal center; Diffuse large B-cell lymphoma; Cancer research; Lymphoma; CD40; B cell; Biology; Gene expression profiling; Cell; Cell culture; Gene expression; Immunology; Antibody; Gene; Cytotoxic T cell; In vitro; Genetics","authors":[{"name":"Annette Hollmann","is_ca":true},{"name":"Raquel Aloyz","is_ca":true},{"name":"Kristi Baker","is_ca":true},{"name":"Stephan Dirnhofer","is_ca":false},{"name":"Trevor Owens","is_ca":false},{"name":"Robert Sladek","is_ca":true},{"name":"Alexandar Tzankov","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01392594052597661,"gpt":0.2678761809839723,"spread":0.2539502404579957,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001320939,0.0001680005,0.0002262376,0.0006374974,0.0002277815,0.0005608946,0.0001462227,0.0002832688,0.001042693],"category_scores_gemma":[0.0003066691,0.0001749464,0.0001392943,0.0004277248,0.0001975872,0.0001714657,0.0001496949,0.000374747,0.0003830275],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003672276,"about_ca_system_score_gemma":0.0001114347,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009677971,"about_ca_topic_score_gemma":0.001098601,"domain_scores_codex":[0.9997566,0.00004233816,0.00002159442,0.00004618946,0.00007389099,0.00005939482],"domain_scores_gemma":[0.9996819,0.0001006002,0.00008247032,0.00004272364,0.00004318143,0.00004911344],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000143576,0.00004057046,0.003301508,0.00001481827,0.000008808905,0.000041805,0.0000446013,0.00006189791,0.9955129,0.0000538485,0.00003694109,0.0007387327],"study_design_scores_gemma":[0.00003246318,0.0006880982,0.1514606,0.000007237156,0.00003651058,0.001464775,0.0001936772,0.001753338,0.8417541,0.0001116585,0.002486226,0.0000111274],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977725,0.0007408251,0.0005439984,0.00002040996,0.000003218199,0.000008442498,0.0003194528,0.00002542916,0.0005657543],"genre_scores_gemma":[0.9969332,0.0003311101,0.000648222,0.00001492212,0.000004084752,0.00002885182,0.001324086,0.000008625453,0.0007068451],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001042693,"threshold_uncertainty_score":0.003488183,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2996879561","doi":"10.1002/hon.2708","title":"Radiotherapy in mantle cell lymphoma: A literature review","year":2019,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Mantle cell lymphoma; Radiation therapy; Lymphoma; Malignancy; Stage (stratigraphy); Disease; Oncology; Internal medicine; Systemic therapy; Cancer","authors":[{"name":"Sharon Ben Barouch","is_ca":true},{"name":"John Kuruvilla","is_ca":true},{"name":"Richard Tsang","is_ca":true},{"name":"Eva Yashphe","is_ca":false},{"name":"Nadav Sarid","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06253466837350785,"gpt":0.3986835428973755,"spread":0.3361488745238677,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005130209,0.0007744462,0.00139509,0.00497566,0.0004038007,0.001086348,0.0009063844,0.0008693782,0.006630071],"category_scores_gemma":[0.00141904,0.0003172032,0.0009182352,0.00541681,0.000444624,0.001461217,0.0006479313,0.001104302,0.001389668],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006811445,"about_ca_system_score_gemma":0.001974258,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0023876,"about_ca_topic_score_gemma":0.003616242,"domain_scores_codex":[0.9997743,0.00003590023,0.00006942293,0.00004404902,0.00006055961,0.00001585225],"domain_scores_gemma":[0.9991024,0.0005553874,0.0001445562,0.00001896238,0.0001434515,0.0000353764],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00008442593,0.00006049241,0.0004118068,0.09692565,0.0001894368,0.0004651527,0.0001628385,0.000384317,0.0006467352,0.001776563,0.03212252,0.8667701],"study_design_scores_gemma":[0.00002690265,0.0001164904,0.002504809,0.06476922,0.001067089,0.006240523,0.0002269215,0.0001253094,0.0003503967,0.002042262,0.9224943,0.00003589338],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001097576,0.998992,0.00004549287,0.0001597769,0.0001032018,0.000004507361,0.00003048979,0.000004163955,0.0005505079],"genre_scores_gemma":[0.0005084474,0.9990082,0.00009369913,0.0001248765,0.0000932309,0.000003826814,0.00003249598,9.358463e-7,0.000134322],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006630071,"threshold_uncertainty_score":0.02217978,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2624535566","doi":"10.1002/hon.2437_81","title":"THE 23‐GENE GENE EXPRESSION‐BASED ASSAY DOES NOT PREDICT INTERIM PET SCAN RESULTS AFTER ABVD IN ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA IN THE US INTERGROUP S0816 TRIAL","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"ABVD; Medicine; Oncology; Clinical endpoint; Lymphoma; Internal medicine; Context (archaeology); Stage (stratigraphy); Interim analysis; Dacarbazine; Surrogate endpoint; Clinical trial; Nuclear medicine; Chemotherapy; Biology; Cyclophosphamide","authors":[{"name":"David W. Scott","is_ca":true},{"name":"H. Li","is_ca":false},{"name":"Yasmin Harvey","is_ca":true},{"name":"Fong Chun Chan","is_ca":true},{"name":"Anja Mottok","is_ca":true},{"name":"M. Boyle","is_ca":true},{"name":"Andrew M. Evens","is_ca":false},{"name":"Heiko Schöder","is_ca":false},{"name":"David J. Straus","is_ca":false},{"name":"Nancy L. Bartlett","is_ca":false},{"name":"John Sweetenham","is_ca":false},{"name":"Paul M. Barr","is_ca":false},{"name":"Michelle A. Fanale","is_ca":false},{"name":"Eric D. Hsi","is_ca":false},{"name":"James R. Cook","is_ca":false},{"name":"Brad S. Kahl","is_ca":false},{"name":"John P. Leonard","is_ca":false},{"name":"Jonathan W. Friedberg","is_ca":false},{"name":"Michael LeBlanc","is_ca":false},{"name":"Christian Steidl","is_ca":true},{"name":"Randy D. Gascoyne","is_ca":true},{"name":"Lisa M. Rimsza","is_ca":false},{"name":"Oliver W. Press","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0370597856809882,"gpt":0.3473945094879564,"spread":0.3103347238069682,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004742295,0.0007708788,0.001292153,0.0002307145,0.0001746988,0.0007391523,0.0004350936,0.0006272822,0.001336406],"category_scores_gemma":[0.002973785,0.0002337401,0.001037702,0.0003595234,0.0006029828,0.0006353232,0.0003572942,0.001265265,0.0003263477],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005586058,"about_ca_system_score_gemma":0.0004519728,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002135334,"about_ca_topic_score_gemma":0.0007719256,"domain_scores_codex":[0.998481,0.001019052,0.0001047659,0.0001652244,0.0001451233,0.00008497328],"domain_scores_gemma":[0.9982166,0.0006844032,0.0005440807,0.0002375921,0.00009681339,0.0002205059],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7279857,0.001832381,0.161657,0.0009181811,0.004482775,0.00021461,0.000316428,0.005402022,0.02113614,0.0002694974,0.002287351,0.0734979],"study_design_scores_gemma":[0.1925531,0.2384978,0.5151262,0.0005251104,0.006869153,0.001526027,0.0002536439,0.01310876,0.01511503,0.00350963,0.01274212,0.0001735084],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996905,0.001507194,0.0002065993,0.0001612999,0.00003559068,0.000137204,0.0003897409,0.00001166659,0.0006458037],"genre_scores_gemma":[0.9971374,0.0003501605,0.0004777455,0.0002534171,0.00005078541,0.000297741,0.001003067,0.000009165962,0.0004203934],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004742295,"threshold_uncertainty_score":0.02507997,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3174532254","doi":"10.1002/hon.51_2879","title":"NIVOLUMAB PLUS BRENTUXIMAB VEDOTIN FOR RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA: EXTENDED FOLLOW‐UP FROM THE PHASE 2 CHECKMATE 436 STUDY","year":2021,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Nivolumab; Refractory (planetary science); Oncology; Phases of clinical research; Gastroenterology; Lymphoma; Surgery; CD30; Chemotherapy; Cancer; Immunotherapy","authors":[{"name":"Pier Luigi Zinzani","is_ca":false},{"name":"Armando Santoro","is_ca":false},{"name":"Giuseppe Gritti","is_ca":false},{"name":"Pauline Brice","is_ca":false},{"name":"Paul M. Barr","is_ca":false},{"name":"John Kuruvilla","is_ca":true},{"name":"David Cunningham","is_ca":false},{"name":"J. Kline","is_ca":false},{"name":"Nathalie A. Johnson","is_ca":true},{"name":"Neha Mehta–Shah","is_ca":false},{"name":"Michelle A. Fanale","is_ca":false},{"name":"Stephen Francis","is_ca":false},{"name":"Alison J. Moskowitz","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04112583095400109,"gpt":0.3361191188900827,"spread":0.2949932879360816,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002161261,0.0009002369,0.001474513,0.0002473399,0.0002981147,0.001065536,0.0006894437,0.0007251184,0.002625272],"category_scores_gemma":[0.0009275958,0.0003658056,0.001714957,0.0003417142,0.0003621557,0.0005533501,0.000381928,0.0015828,0.0005576704],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000695143,"about_ca_system_score_gemma":0.0008245254,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008248236,"about_ca_topic_score_gemma":0.001910563,"domain_scores_codex":[0.9995812,0.0001955308,0.00002533422,0.00007070955,0.00006354317,0.00006374297],"domain_scores_gemma":[0.999418,0.00009974725,0.0001649911,0.00007222658,0.00004509414,0.0001999422],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7865387,0.01933356,0.0355845,0.002134955,0.00642474,0.000422871,0.000295857,0.004124091,0.02165233,0.000227592,0.005806655,0.1174542],"study_design_scores_gemma":[0.522679,0.3148068,0.1366428,0.0002820621,0.006222775,0.001021057,0.00009949577,0.002565521,0.004297062,0.0003365882,0.01097447,0.00007228855],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9894107,0.004917311,0.0003070901,0.0001679388,0.00007316036,0.001161363,0.002370473,0.00005076731,0.001541212],"genre_scores_gemma":[0.9859706,0.002901613,0.0007231346,0.0007266281,0.0001508107,0.001156447,0.006633383,0.0000214774,0.001715938],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002625272,"threshold_uncertainty_score":0.01143003,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4380084938","doi":"10.1002/hon.3163_95","title":"GLOFITAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY (<i>R</i>/<i>R</i>) LARGE B‐CELL LYMPHOMA (LBCL): EXTENDED FOLLOW‐UP AND LANDMARK ANALYSES FROM A PIVOTAL PHASE II STUDY","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Roche (Canada)","funders":"Kite Pharma; F. Hoffmann-La Roche; Genentech; Celgene; Gilead Sciences; Pharmacyclics; Sanofi; Pfizer; Bristol-Myers Squibb","keywords":"Refractory (planetary science); Medicine; Lymphoma; Oncology; Internal medicine; Physics","authors":[{"name":"Michael Dickinson","is_ca":false},{"name":"Carmelo Carlo‐Stella","is_ca":false},{"name":"Franck Morschhauser","is_ca":false},{"name":"Lorenzo Falchi","is_ca":false},{"name":"Emmanuel Bachy","is_ca":false},{"name":"Guillaume Cartron","is_ca":false},{"name":"Cyrus Khan","is_ca":false},{"name":"Monica Tani","is_ca":false},{"name":"Joaquín Martínez‐López","is_ca":false},{"name":"Nancy L. Bartlett","is_ca":false},{"name":"Antonio Salar","is_ca":false},{"name":"Joshua Brody","is_ca":false},{"name":"Sirpa Leppä","is_ca":false},{"name":"E. Mulvihill","is_ca":false},{"name":"Linda Lundberg","is_ca":false},{"name":"James Relf","is_ca":false},{"name":"Youhua Xie","is_ca":true},{"name":"Alessia Bottos","is_ca":false},{"name":"K. Humphrey","is_ca":false},{"name":"Martin Hutchings","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04688872729011315,"gpt":0.3771005735176207,"spread":0.3302118462275075,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009010204,0.0004317646,0.0009886416,0.0002199358,0.0001658215,0.0006701496,0.0004123771,0.000397276,0.001003783],"category_scores_gemma":[0.0007291725,0.0002200341,0.0006833649,0.0003192133,0.0002169797,0.0005251792,0.0002397502,0.0009929239,0.0003147199],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006624802,"about_ca_system_score_gemma":0.0004517262,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004362001,"about_ca_topic_score_gemma":0.001595823,"domain_scores_codex":[0.9997485,0.0001103013,0.00002297893,0.00004442945,0.00003379224,0.00003994094],"domain_scores_gemma":[0.9995328,0.00008211133,0.0001678916,0.00004304761,0.00002790159,0.0001462821],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4746427,0.01013743,0.1368658,0.001323058,0.00300796,0.0008809454,0.0006795295,0.005144469,0.07063378,0.0002187825,0.007032433,0.2894332],"study_design_scores_gemma":[0.1283813,0.3847013,0.4515344,0.0002467367,0.002705544,0.002297858,0.0002893141,0.003767891,0.0107325,0.0003750537,0.01485221,0.0001159137],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949312,0.003255774,0.0001831809,0.0001625092,0.00002324532,0.0001638259,0.0004874041,0.00003557442,0.0007572419],"genre_scores_gemma":[0.9964716,0.001156664,0.0003575151,0.000226434,0.0000432936,0.0001253519,0.001223785,0.000008024159,0.000387342],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001003783,"threshold_uncertainty_score":0.004806638,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2142220672","doi":"10.1002/hon.2266","title":"Non‐Hodgkin lymphoma in Romania: a single‐centre experience","year":2015,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"","keywords":"Hodgkin lymphoma; Lymphoma; Medicine; Internal medicine","authors":[{"name":"Bogdan Fetică","is_ca":false},{"name":"Patriciu Achimaș-Cădariu","is_ca":false},{"name":"Bogdan Pop","is_ca":false},{"name":"Delia Dima","is_ca":false},{"name":"L. N. Petrov","is_ca":false},{"name":"Anamarija M. Perry","is_ca":true},{"name":"Bharat N. Nathwani","is_ca":false},{"name":"Hans Konrad Müller‐Hermelink","is_ca":false},{"name":"J Diébold","is_ca":false},{"name":"Kenneth MacLennan","is_ca":false},{"name":"Annamaria Fulop","is_ca":false},{"name":"Mihaiela L. Blaga","is_ca":false},{"name":"Daniela Coza","is_ca":false},{"name":"Florian Al. Nicula","is_ca":false},{"name":"Alexandru Irimie","is_ca":false},{"name":"Dennis D. Weisenburger","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06943261231885393,"gpt":0.3354643070766122,"spread":0.2660316947577582,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006542628,0.0003683142,0.000445378,0.00093684,0.000769448,0.0006822915,0.0004845046,0.0004500105,0.00127213],"category_scores_gemma":[0.002004827,0.0003794238,0.0003398524,0.001065761,0.000642036,0.0004383756,0.001003581,0.0003282518,0.0003189648],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006051997,"about_ca_system_score_gemma":0.0007186175,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002565323,"about_ca_topic_score_gemma":0.003521971,"domain_scores_codex":[0.9995058,0.0001547019,0.00006467284,0.00007897191,0.00006522939,0.000130677],"domain_scores_gemma":[0.9993021,0.0001220297,0.0002340893,0.0001074686,0.00006060408,0.0001736542],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00009855587,0.0001449226,0.9625641,0.00009244094,0.00003550434,0.02365606,0.001589069,0.0000889878,0.0006122438,0.00007569552,0.0003984361,0.01064398],"study_design_scores_gemma":[0.00006610328,0.0005304342,0.9053293,0.00009780068,0.0000528857,0.08683942,0.003319512,0.0002601932,0.0003558544,0.00007282028,0.003050938,0.00002471671],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979381,0.0008732904,0.0001651482,0.00007465597,0.00001178795,0.00002831006,0.0000582333,0.00000609378,0.0008443195],"genre_scores_gemma":[0.9986891,0.0007718157,0.0001446352,0.0001002651,0.00002258054,0.00001677555,0.00009032311,0.0000036847,0.0001607457],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002565323,"threshold_uncertainty_score":0.005100787,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3092926650","doi":"10.1002/hon.2818","title":"Clinical trial risk in leukemia: Biomarkers and trial design","year":2020,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Celiac Association; University of Toronto","funders":"","keywords":"Medicine; Myeloid leukemia; Clinical trial; Oncology; Chronic lymphocytic leukemia; Biomarker; Internal medicine; Drug; Leukemia; Pharmacology","authors":[{"name":"Alice Li","is_ca":true},{"name":"Jasper P. Dhanraj","is_ca":true},{"name":"Gilberto Lopes","is_ca":false},{"name":"Jayson L. Parker","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3097116344433638,"gpt":0.5104696459623587,"spread":0.2007580115189949,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.3301918,0.003159429,0.007064525,0.005565762,0.001583113,0.00609727,0.003341233,0.006593737,0.01356057],"category_scores_gemma":[0.4189123,0.001447472,0.009174042,0.006770014,0.003620228,0.007541264,0.005314756,0.005666637,0.002097029],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004291426,"about_ca_system_score_gemma":0.005028767,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005535766,"about_ca_topic_score_gemma":0.00071874,"domain_scores_codex":[0.4392459,0.4791464,0.03730494,0.02167478,0.0190314,0.003596479],"domain_scores_gemma":[0.639095,0.2354928,0.07692763,0.02804267,0.01582882,0.004613063],"domain_codex":"methods","domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.2319957,0.002279617,0.2234135,0.04315653,0.09330988,0.001285583,0.001934295,0.02297989,0.001640682,0.09581462,0.04212689,0.2400627],"study_design_scores_gemma":[0.1031708,0.054886,0.0949172,0.02435027,0.0774494,0.003264788,0.001215108,0.1335144,0.005574598,0.2818388,0.2185052,0.001313455],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"methods","genre_gemma":"review","genre_scores_codex":[0.1733091,0.1891104,0.3238182,0.01795491,0.01237056,0.2416513,0.01311472,0.001438292,0.02723262],"genre_scores_gemma":[0.6166656,0.007130179,0.09789219,0.008935494,0.002551583,0.2579056,0.003916426,0.0004181516,0.004584765],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.3301918,"threshold_uncertainty_score":0.8259928,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1509594523","doi":"10.1002/hon.2165","title":"Use of non‐steroidal anti‐inflammatory drugs and risk of non‐Hodgkin lymphoma: a systematic review and meta‐analysis","year":2014,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; Manitoba Health; Winnipeg Regional Health Authority","funders":"ExxonMobil Research and Engineering Company","keywords":"Medicine; Internal medicine; Odds ratio; Follicular lymphoma; Lymphoma; Epidemiology; Confidence interval; Meta-analysis; Oncology; Aspirin; Chronic lymphocytic leukemia; Relative risk; Leukemia","authors":[{"name":"Xibiao Ye","is_ca":true},{"name":"Natalie Casaclang","is_ca":true},{"name":"Salaheddin M. Mahmud","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06019436790171891,"gpt":0.35641511288956,"spread":0.2962207449878411,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01315382,0.002469364,0.01628605,0.008892272,0.0006108333,0.003076692,0.002010423,0.001948759,0.002617966],"category_scores_gemma":[0.03398213,0.001694655,0.03082623,0.01120375,0.0006320763,0.001604312,0.001519524,0.001404561,0.0002738919],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002809806,"about_ca_system_score_gemma":0.003866788,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006520038,"about_ca_topic_score_gemma":0.01545011,"domain_scores_codex":[0.9896855,0.004706894,0.003329275,0.000884004,0.001108779,0.0002856113],"domain_scores_gemma":[0.9791034,0.01534427,0.003110019,0.0005536559,0.001657159,0.0002313217],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001158174,0.00002453774,0.00521731,0.4428807,0.5343909,0.0001989915,0.0001112288,0.0005737823,0.0001961383,0.0001317212,0.0006764645,0.01443996],"study_design_scores_gemma":[0.0002596814,0.0001402417,0.003873711,0.02973756,0.9636359,0.0001653839,0.00005152522,0.0001618809,0.0001173695,0.0001538114,0.001682151,0.00002090476],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003486842,0.9952877,0.0003579461,0.0001202087,0.00008659578,0.0001771553,0.0003042061,0.00001359963,0.0001657719],"genre_scores_gemma":[0.08246548,0.9138108,0.001703448,0.0004271109,0.0001441562,0.0007062112,0.000519938,0.00001559388,0.0002072627],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01628605,"threshold_uncertainty_score":0.06956488,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1948948104","doi":"10.1002/hon.2176","title":"Economic evaluation of arsenic trioxide for treatment of newly diagnosed acute promyelocytic leukaemia in Canada","year":2014,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Université de Montréal","funders":"Lundbeck Canada","keywords":"Medicine; Arsenic trioxide; Adverse effect; Internal medicine; Cost effectiveness; Quality-adjusted life year; Cost-effectiveness analysis","authors":[{"name":"Jean Lachaîne","is_ca":true},{"name":"Karine Mathurin","is_ca":true},{"name":"Stéphane Barakat","is_ca":false},{"name":"Andre C. Schuh","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02308680159429484,"gpt":0.3040223660789609,"spread":0.2809355644846661,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004496503,0.001026225,0.001463984,0.001656433,0.001091029,0.00258287,0.001375741,0.0008691276,0.003174249],"category_scores_gemma":[0.013607,0.0005093298,0.002152538,0.002680072,0.0006806192,0.0005652528,0.0009634295,0.001320697,0.00009374581],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.1001109,"about_ca_system_score_gemma":0.09588506,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9619535,"about_ca_topic_score_gemma":0.9501696,"domain_scores_codex":[0.9970108,0.001549532,0.0001054249,0.0001315409,0.0006521865,0.0005505616],"domain_scores_gemma":[0.9953934,0.002040497,0.0004343662,0.00008325837,0.001418036,0.0006304556],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.0154595,0.0007765857,0.02505437,0.003242741,0.003513891,0.0006260829,0.0002126373,0.8715972,0.001391662,0.01578052,0.008783678,0.05356116],"study_design_scores_gemma":[0.007374641,0.003724205,0.0609054,0.001425478,0.005162013,0.0003801788,0.001114173,0.8918863,0.001722501,0.005223205,0.02077309,0.0003087985],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8931144,0.03218491,0.006172152,0.008376553,0.0002840927,0.00321319,0.01439536,0.0001471803,0.04211212],"genre_scores_gemma":[0.9908133,0.003839267,0.001718057,0.000326161,0.00001835062,0.0002148994,0.001354413,0.00001276283,0.001702698],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1001109,"threshold_uncertainty_score":0.7263585,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2623329013","doi":"10.1002/hon.2438_50","title":"PHASE 1B STUDY OF PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE <scp>B</scp>‐CELL LYMPHOMA (<scp>RRPMBCL</scp>): UPDATED RESULTS FROM THE <scp>KEYNOTE</scp>‐013 TRIAL","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Tolerability; Neutropenia; Internal medicine; Pembrolizumab; Regimen; Adverse effect; Population; Cohort; Refractory (planetary science); Surgery; Oncology; Gastroenterology; Toxicity; Cancer; Immunotherapy","authors":[{"name":"Pier Luigi Zinzani","is_ca":false},{"name":"Vincent Ribrag","is_ca":false},{"name":"Craig H. Moskowitz","is_ca":false},{"name":"Jean‐Marie Michot","is_ca":false},{"name":"John Kuruvilla","is_ca":true},{"name":"Nancy L. Bartlett","is_ca":false},{"name":"Arun Balakumaran","is_ca":false},{"name":"Arkendu Chatterjee","is_ca":false},{"name":"Sabine Chlosta","is_ca":false},{"name":"Margaret A. Shipp","is_ca":false},{"name":"Philippe Armand","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02672170501286256,"gpt":0.3030244134812918,"spread":0.2763027084684293,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001672764,0.0008896743,0.000866638,0.0001996278,0.0002737094,0.0006790416,0.0005103601,0.0008653702,0.005004791],"category_scores_gemma":[0.0008169934,0.0003523194,0.0009099247,0.0002996135,0.0003996681,0.0007494004,0.0002732625,0.002175596,0.0009193242],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000711589,"about_ca_system_score_gemma":0.000883372,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008528855,"about_ca_topic_score_gemma":0.002226391,"domain_scores_codex":[0.9997136,0.0001465523,0.0000135248,0.00004564198,0.000034706,0.0000460593],"domain_scores_gemma":[0.9996049,0.000074796,0.000113574,0.00003779251,0.00003045943,0.0001384889],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8026888,0.02018926,0.01276689,0.001751916,0.002790783,0.0002893301,0.0003032013,0.002018949,0.03245188,0.0004406634,0.01478805,0.1095203],"study_design_scores_gemma":[0.872005,0.08896033,0.02753482,0.0001052052,0.0009958555,0.0004479034,0.00006157548,0.001105687,0.002298405,0.0003750623,0.006087508,0.00002273743],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9805676,0.005788707,0.0007401397,0.001186368,0.0001712938,0.002572952,0.003989702,0.0001063043,0.004877],"genre_scores_gemma":[0.9834024,0.002750632,0.001577089,0.001462103,0.0001551781,0.002242627,0.005356832,0.00003702156,0.003016115],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005004791,"threshold_uncertainty_score":0.01674271,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2949814266","doi":"10.1002/hon.118_2630","title":"CORRELATIVE ANALYSES OF CYTOKINE RELEASE SYNDROME AND NEUROLOGICAL EVENTS IN TISAGENLECLEUCEL‐TREATED RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS","year":2019,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Maisonneuve-Rosemont; McMaster University","funders":"","keywords":"Cytokine release syndrome; Medicine; Internal medicine; Refractory (planetary science); Gastroenterology; Clinical endpoint; Lymphoma; Diffuse large B-cell lymphoma; Phases of clinical research; Cytokine; Peripheral T-cell lymphoma; Clinical trial; Immunotherapy; Immunology; T cell; Immune system; Cancer; Biology","authors":[{"name":"Veronika Bachanová","is_ca":false},{"name":"Jason R. Westin","is_ca":false},{"name":"Constantine S. Tam","is_ca":false},{"name":"Peter Borchmann","is_ca":false},{"name":"Ulrich Jaeger","is_ca":false},{"name":"Joseph P. McGuirk","is_ca":false},{"name":"Harald Holte","is_ca":false},{"name":"Edmund K. Waller","is_ca":false},{"name":"Samantha Jaglowski","is_ca":false},{"name":"Michael Bishop","is_ca":false},{"name":"Charalambos Andreadis","is_ca":false},{"name":"S.R. Foley","is_ca":true},{"name":"Isabelle Fleury","is_ca":true},{"name":"Takanori Teshima","is_ca":false},{"name":"Stephan Mielke","is_ca":false},{"name":"Gilles Salles","is_ca":false},{"name":"P. Joy Ho","is_ca":false},{"name":"Koji Izutsu","is_ca":false},{"name":"Richard T. Maziarz","is_ca":false},{"name":"Koen van Besien","is_ca":false},{"name":"Marie José Kersten","is_ca":false},{"name":"Nina Wagner‐Johnston","is_ca":false},{"name":"Koji Kato","is_ca":false},{"name":"Paolo Corradini","is_ca":false},{"name":"Xingmin Han","is_ca":false},{"name":"Sergei Agoulnik","is_ca":false},{"name":"J. Chu","is_ca":false},{"name":"Lamis Eldjerou","is_ca":false},{"name":"Lida Pacaud","is_ca":false},{"name":"Stephen J. Schuster","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03648638014391697,"gpt":0.3376116835436119,"spread":0.301125303399695,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001355557,0.0002233184,0.0005541256,0.0003415637,0.0001494568,0.0004566834,0.0002640887,0.000208911,0.0006612779],"category_scores_gemma":[0.001274498,0.0001034782,0.0002813709,0.0004120431,0.0001682151,0.0002497708,0.0002322668,0.0004687381,0.0001551747],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004610153,"about_ca_system_score_gemma":0.0003035221,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003514274,"about_ca_topic_score_gemma":0.0007389121,"domain_scores_codex":[0.9994797,0.0002387619,0.00006038216,0.00007519635,0.00009565082,0.00005026158],"domain_scores_gemma":[0.9987046,0.0003051658,0.0005845233,0.00006364433,0.0001719399,0.0001702097],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03244982,0.00122489,0.8463849,0.0003743767,0.0007277987,0.001013614,0.0002710837,0.00101784,0.02774513,0.000078777,0.00124174,0.08746991],"study_design_scores_gemma":[0.00233172,0.0268707,0.9552587,0.00004543733,0.0005747422,0.002250922,0.0001382121,0.001768463,0.006742098,0.00009225059,0.003901554,0.00002508916],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975726,0.00140277,0.0001641868,0.00004864061,0.000006358623,0.00005378657,0.0002563731,0.00001072153,0.0004846616],"genre_scores_gemma":[0.9984803,0.0003252088,0.00022539,0.00009734174,0.00001834892,0.00004885799,0.0006620369,0.000003179348,0.0001394098],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001355557,"threshold_uncertainty_score":0.007168949,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2624425537","doi":"10.1002/hon.2437_13","title":"DURABLE BENEFIT OF RITUXIMAB MAINTENANCE POST‐AUTOGRAFT IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA: 12‐YEAR FOLLOW‐UP OF THE EBMT LYMPHOMA WORKING PARTY LYM1 TRIAL","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Rituximab; Medicine; Autologous stem-cell transplantation; Follicular lymphoma; Maintenance therapy; Internal medicine; Surgery; Oncology; Lymphoma; Salvage therapy; Chemotherapy; Progression-free survival","authors":[{"name":"Ruth Pettengell","is_ca":false},{"name":"Rahman Uddin","is_ca":false},{"name":"Ariane Boumendil","is_ca":false},{"name":"Steve Robinson","is_ca":false},{"name":"Genea Smith","is_ca":false},{"name":"T Hawkins","is_ca":false},{"name":"Bernd Metzner","is_ca":false},{"name":"Marı́a Dolores Caballero","is_ca":false},{"name":"Hervé Tilly","is_ca":false},{"name":"Joanna Romejko‐Jarosińska","is_ca":false},{"name":"I. Bence‐Bruckler","is_ca":true},{"name":"Bik To","is_ca":false},{"name":"Carsten Utoft Niemann","is_ca":false},{"name":"Eva Kimby","is_ca":false},{"name":"Peter Dreger","is_ca":false},{"name":"Norbert Schmitz","is_ca":false},{"name":"A. H. Goldstone","is_ca":false},{"name":"Silvia Montoto","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02219643157301769,"gpt":0.2645807255552944,"spread":0.2423842939822767,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002155029,0.0006450717,0.001531154,0.0001879448,0.0003387953,0.0009449279,0.0005814711,0.001140406,0.001877967],"category_scores_gemma":[0.001237246,0.0002797156,0.001284258,0.0002476523,0.0005675902,0.0007557656,0.000295488,0.002128782,0.000455348],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005421945,"about_ca_system_score_gemma":0.0004186065,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004554366,"about_ca_topic_score_gemma":0.000885943,"domain_scores_codex":[0.9994084,0.0003217793,0.00003096489,0.00008102583,0.00004680671,0.0001110631],"domain_scores_gemma":[0.9990139,0.0002567453,0.0002800954,0.0001403589,0.00004040844,0.0002684716],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9012645,0.008519542,0.01499802,0.0004463036,0.002693185,0.0001685089,0.0001477827,0.001122421,0.006697941,0.000116047,0.001536377,0.06228936],"study_design_scores_gemma":[0.4680761,0.4156613,0.1040826,0.0001364485,0.003344178,0.0004725886,0.00009435542,0.001400557,0.003081343,0.0003765161,0.003223031,0.00005087871],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949281,0.003541557,0.0001547476,0.0002481571,0.0000645297,0.00014519,0.0002908769,0.00002079344,0.0006061014],"genre_scores_gemma":[0.9968504,0.0008523382,0.0001428696,0.0003376436,0.0001325482,0.000198898,0.0006492356,0.00000625273,0.0008297817],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002155029,"threshold_uncertainty_score":0.01139706,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2622354226","doi":"10.1002/hon.2437_76","title":"CANADIAN CANCER TRIALS GROUP (CCTG) LY.17: A RANDOMIZED PHASE II STUDY EVALUATING NOVEL SALVAGE THERAPY PRE‐AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RR‐DLBCL) ‐ OUTCOME OF IBRUTINIB + R‐GDP","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Canadian Cancer Society","funders":"","keywords":"Medicine; Internal medicine; Rituximab; Salvage therapy; Interim analysis; Oncology; Clinical endpoint; Gemcitabine; Febrile neutropenia; Diffuse large B-cell lymphoma; Population; Neutropenia; Ibrutinib; Chemotherapy regimen; Surgery; Chemotherapy; Randomized controlled trial; Lymphoma; Leukemia","authors":[{"name":"John Kuruvilla","is_ca":true},{"name":"M. Crump","is_ca":true},{"name":"Diego Villa","is_ca":true},{"name":"Muhammad Imran Aslam","is_ca":true},{"name":"Anca Prica","is_ca":true},{"name":"David W. Scott","is_ca":true},{"name":"Nanees Abd-Elsamad","is_ca":true},{"name":"Stephen Couban","is_ca":true},{"name":"Stéphane Doucet","is_ca":true},{"name":"Jill Dudebout","is_ca":true},{"name":"Isabelle Fleury","is_ca":true},{"name":"Graeme Fraser","is_ca":true},{"name":"Jean-François Larouche","is_ca":true},{"name":"Mona Shafey","is_ca":true},{"name":"Pamela Skrabek","is_ca":true},{"name":"Tanya Skamene","is_ca":true},{"name":"Chad Winch","is_ca":true},{"name":"L. E. Shepherd","is_ca":true},{"name":"B.E. Chen","is_ca":true},{"name":"Annette E. Hay","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1357148248903003,"gpt":0.442831365213154,"spread":0.3071165403228537,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002618583,0.001821019,0.002399324,0.0004156542,0.0008820234,0.001169329,0.001213058,0.001915559,0.009096562],"category_scores_gemma":[0.001775999,0.0005096964,0.001773194,0.0008309856,0.001204571,0.0005108828,0.000465402,0.003676388,0.001249911],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004666316,"about_ca_system_score_gemma":0.01192897,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.05035957,"about_ca_topic_score_gemma":0.1499393,"domain_scores_codex":[0.9992328,0.0003790582,0.00002598622,0.0001028032,0.0001250865,0.0001343524],"domain_scores_gemma":[0.9990466,0.000135998,0.0002022665,0.00006197614,0.0001301986,0.0004229448],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9076625,0.01011642,0.00292222,0.002451529,0.002061327,0.000152086,0.0001700071,0.000924024,0.004059155,0.000641208,0.01867011,0.05016951],"study_design_scores_gemma":[0.9565618,0.0340093,0.00324536,0.00009630129,0.000653587,0.00006989976,0.00002734569,0.0003043404,0.0002527806,0.0001736857,0.004588005,0.00001750508],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9045854,0.0194857,0.001182673,0.007211948,0.001511796,0.03650774,0.01555166,0.0004096477,0.01355335],"genre_scores_gemma":[0.8934196,0.0134073,0.007764865,0.01018476,0.001072068,0.04060752,0.01574785,0.0001487336,0.01764722],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05035957,"threshold_uncertainty_score":0.1001329,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4379981852","doi":"10.1002/hon.3166_ot28","title":"PHASE 3 TRIAL OF SUBCUTANEOUS EPCORITAMAB + R‐CHOP VERSUS R‐CHOP IN PATIENTS (PTS) WITH NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): EPCORE DLBCL‐2","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"National Institutes of Health; National Cancer Institute; Celgene; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Rituximab; Diffuse large B-cell lymphoma; Vincristine; Cytokine release syndrome; Oncology; Prednisone; CHOP; International Prognostic Index; Cyclophosphamide; Phases of clinical research; CD20; Lymphoma; Discontinuation; Gastroenterology; Clinical trial; Chemotherapy; Cancer; Immunotherapy","authors":[{"name":"Laurie H. Sehn","is_ca":true},{"name":"Martine E.D. Chamuleau","is_ca":false},{"name":"Georg Lenz","is_ca":false},{"name":"Michael Roost Clausen","is_ca":false},{"name":"Corinne Haïoun","is_ca":false},{"name":"Koji Izutsu","is_ca":false},{"name":"Andrew Davies","is_ca":false},{"name":"Jun Zhu","is_ca":false},{"name":"Toshihiko Oki","is_ca":false},{"name":"Edith Szafer‐Glusman","is_ca":false},{"name":"R. Conlon","is_ca":false},{"name":"Hung‐Yi Chiou","is_ca":false},{"name":"David Ipe","is_ca":false},{"name":"Baxter A. Elliot","is_ca":false},{"name":"Gilles Salles","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04596949735079359,"gpt":0.360199123689225,"spread":0.3142296263384314,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001542606,0.001940556,0.0017751,0.0002856473,0.0003188195,0.001031447,0.0009639435,0.001190194,0.005542737],"category_scores_gemma":[0.001031003,0.0005843755,0.00132476,0.0003314195,0.0009241509,0.0008370545,0.0004009505,0.004449605,0.001489863],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008989691,"about_ca_system_score_gemma":0.00128654,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001120435,"about_ca_topic_score_gemma":0.002846234,"domain_scores_codex":[0.9996784,0.0001695026,0.00001056271,0.00005462499,0.00002483282,0.00006211377],"domain_scores_gemma":[0.999428,0.0001153357,0.0001038677,0.00005487726,0.00003025516,0.0002676332],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9219002,0.02358753,0.001537584,0.0004901231,0.000761205,0.0001239116,0.0001254895,0.001315842,0.009798429,0.000224059,0.003433753,0.03670191],"study_design_scores_gemma":[0.8509995,0.142425,0.003263655,0.00002606717,0.0002418754,0.0001238539,0.00002937141,0.0009786002,0.0006384714,0.0002148586,0.001042964,0.00001589423],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9871922,0.002012041,0.0006604421,0.0009065474,0.0004089741,0.003391447,0.001707352,0.0002460768,0.00347505],"genre_scores_gemma":[0.9835801,0.001453862,0.001727876,0.001609623,0.0002999625,0.003863232,0.003270995,0.00004905989,0.004145272],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005542737,"threshold_uncertainty_score":0.01854229,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2107886618","doi":"10.1002/hon.2048","title":"Successful treatment of non‐Hodgkin lymphoma associated immune thrombocytopenia with involved field radiotherapy","year":2013,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lymphoma; Thrombocytopenic purpura; Immune system; Chemotherapy; Radiation therapy; Immunology; Antibody; clone (Java method); Oncology; Internal medicine; Biology","authors":[{"name":"Tanya Berrang","is_ca":true},{"name":"Caroline Holloway","is_ca":true},{"name":"Jason Hart","is_ca":true},{"name":"Adrian Yee","is_ca":true},{"name":"Brian Berry","is_ca":true},{"name":"Rami Kotb","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02274352515073857,"gpt":0.3064587636854287,"spread":0.2837152385346901,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002643651,0.000474191,0.0007928563,0.0005526443,0.0003957147,0.0003130746,0.0005616288,0.000733641,0.0008355006],"category_scores_gemma":[0.001031909,0.0002191395,0.0007052886,0.0003703303,0.0004788999,0.0003206499,0.0005162999,0.0008451263,0.0004850624],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002703783,"about_ca_system_score_gemma":0.0002650455,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003374598,"about_ca_topic_score_gemma":0.0006316885,"domain_scores_codex":[0.9998079,0.00004385902,0.00002183176,0.00002645157,0.00004127583,0.00005880667],"domain_scores_gemma":[0.999785,0.00006270423,0.00003764369,0.00006155127,0.00001218883,0.00004092768],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.00349711,0.00322316,0.04871759,0.001336501,0.0006805967,0.4358041,0.001257738,0.008247529,0.07055036,0.001888887,0.003108352,0.4216881],"study_design_scores_gemma":[0.001899431,0.01720021,0.1369221,0.0003796402,0.0008510209,0.7608973,0.00024983,0.007313528,0.041605,0.003011504,0.02956883,0.0001016908],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9670839,0.01321524,0.008428778,0.0008785145,0.0002844649,0.0002420643,0.00009488273,0.0003049797,0.009467287],"genre_scores_gemma":[0.9927198,0.003995013,0.001351206,0.000352045,0.0002810626,0.00005752953,0.0001083539,0.0000457939,0.001089358],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008355006,"threshold_uncertainty_score":0.002795041,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385144282","doi":"10.1002/hon.3205","title":"Personalised therapy in follicular lymphoma – is the dial turning?","year":2023,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Cancer Institute; Genentech; Terry Fox Foundation; ViewRay; Cancer Research UK; Incyte; Eisai; BeiGene; National Cancer Research Institute; AstraZeneca; Celgene; Blood Cancer UK; Gilead Sciences","keywords":"Follicular lymphoma; Medicine; Dial; Oncology; Lymphoma; Internal medicine; Engineering","authors":[{"name":"Kim Linton","is_ca":false},{"name":"Lena Specht","is_ca":false},{"name":"Astrid Pavlovsky","is_ca":false},{"name":"Carrie A. Thompson","is_ca":false},{"name":"Eva Kimby","is_ca":false},{"name":"Daphne de Jong","is_ca":false},{"name":"Loretta J. Nastoupil","is_ca":false},{"name":"Anne‐Ségolène Cottereau","is_ca":false},{"name":"Carla Casulo","is_ca":false},{"name":"Clémentine Sarkozy","is_ca":false},{"name":"Jessica Okosun","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1364764441912303,"gpt":0.4095612211108426,"spread":0.2730847769196124,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005869799,0.0003735645,0.001058367,0.0009459227,0.0001756956,0.0009199594,0.000612238,0.0008161635,0.003712279],"category_scores_gemma":[0.001045255,0.0001510199,0.0005362994,0.0008365625,0.0002777459,0.001042372,0.0004973913,0.001544634,0.001353851],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004448015,"about_ca_system_score_gemma":0.0006585217,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006898761,"about_ca_topic_score_gemma":0.001455161,"domain_scores_codex":[0.9998181,0.00005596331,0.00002834331,0.00002599728,0.00005387465,0.00001766606],"domain_scores_gemma":[0.9996668,0.0002044782,0.00003998851,0.000009962912,0.00006238024,0.00001638795],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000078324,0.0000351189,0.0001093349,0.01757818,0.0001204175,0.0001127701,0.00006094192,0.000249284,0.0006473721,0.003036915,0.025917,0.9520543],"study_design_scores_gemma":[0.00003434663,0.0001118479,0.000664547,0.01117154,0.0001880697,0.001444478,0.00007101337,0.00009424319,0.0002578261,0.002598014,0.9833493,0.00001470298],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009096272,0.9986455,0.00008044523,0.000442868,0.0001577427,0.000003113298,0.00001312683,0.000004971767,0.0005612951],"genre_scores_gemma":[0.0006938959,0.9982964,0.0001301707,0.0003684997,0.0001520969,0.000004848644,0.00002249595,0.000001509671,0.0003300115],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003712279,"threshold_uncertainty_score":0.01241875,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}